TET1 |
Tet methylcytosine dioxygenase 1 |
Methylcytosine dioxygenase TET1 |
prognosis(unfavorable) |
34731191 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
diagnosis |
34418427 |
View |
ARID1A |
AT-rich interaction domain 1A |
AT-rich interactive domain-containing protein 1A |
treatment(immune checkpoint inhibitor respons) |
32594230 |
View |
mesothelin |
mesothelin |
Mesothelin |
diagnosis(risk group) |
32468249 |
View |
mesothelin |
mesothelin |
Mesothelin |
prognosis(unfavorable) |
32468249 |
View |
mesothelin |
mesothelin |
Mesothelin |
prognosis(unfavorable) |
32468249 |
View |
CA125 |
Mucin 16, cell surface associated |
Mucin-16 |
diagnosis(risk group) |
32468249 |
View |
CA125 |
Mucin 16, cell surface associated |
Mucin-16 |
prognosis(unfavorable) |
32468249 |
View |
CA125 |
Mucin 16, cell surface associated |
Mucin-16 |
prognosis(unfavorable) |
32468249 |
View |
KLF5 |
Kruppel like factor 5 |
Krueppel-like factor 5 |
prognosis(unfavorable) |
32451988 |
View |
KLF11 |
KLF transcription factor 11 |
Krueppel-like factor 11 |
prognosis(unfavorable) |
32451988 |
View |
KLF5 |
Kruppel like factor 5 |
Krueppel-like factor 5 |
prognosis(unfavorable) |
32451988 |
View |
IMP3 |
IMP U3 small nucleolar ribonucleoprotein 3 |
U3 small nucleolar ribonucleoprotein protein IMP3 |
diagnosis |
34418427 |
View |
KLF11 |
KLF transcription factor 11 |
Krueppel-like factor 11 |
prognosis(unfavorable) |
32451988 |
View |
COX-2 |
Mitochondrially encoded cytochrome c oxidase II |
Cytochrome c oxidase subunit 2 |
prognosis(unfavorable) |
32433831 |
View |
RRBP1 |
Ribosome binding protein 1 |
Ribosome-binding protein 1 |
prognosis(unfavorable) |
30684972 |
View |
RRBP1 |
Ribosome binding protein 1 |
Ribosome-binding protein 1 |
treatment(therapeutic target) |
30684972 |
View |
SNF5 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 |
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 |
treatment(therapeutic target) |
30683081 |
View |
STC2 |
Stanniocalcin 2 |
Stanniocalcin-2 |
prognosis(unfavorable) |
30661222 |
View |
GDF-15 |
growth differentiation factor 15 |
Growth/differentiation factor 15 |
prognosis(unfavorable) |
30645608 |
View |
the total amount of microparticles |
N/A |
N/A |
diagnosis |
30618036 |
View |
endothelial (CD144+) |
N/A |
Cadherin-5 |
diagnosis |
30618036 |
View |
endothelial (CD144+) |
N/A |
Cadherin-5 |
treatment |
30618036 |
View |
L1CAM |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
diagnosis |
34418427 |
View |
monocytic (CD14+) |
N/A |
N/A |
diagnosis |
30618036 |
View |
monocytic (CD14+) |
N/A |
N/A |
treatment |
30618036 |
View |
the total amount of microparticles |
N/A |
N/A |
treatment |
30618036 |
View |
IMP3 |
IMP U3 small nucleolar ribonucleoprotein 3 |
U3 small nucleolar ribonucleoprotein protein IMP3 |
diagnosis |
30614088 |
View |
SMOC-2 |
SPARC related modular calcium binding 2 |
SPARC-related modular calcium-binding protein 2 |
treatment(therapeutic target, enhanced resistance toward chemotherapy) |
30594556 |
View |
L1CAM |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
diagnosis(aggressive tumor behavior and recurrence risk) |
30591489 |
View |
L1CAM |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
diagnosis(pre-operative predictor of lymph node involvement) |
30557309 |
View |
PD-L1 |
CD274 molecule |
Programmed cell death 1 ligand 1 |
prognosis(unfavorable) |
30539847 |
View |
HIF-1α |
hypoxia inducible factor 1 subunit alpha |
Hypoxia-inducible factor 1-alpha inhibitor |
prognosis(unfavorable) |
30539847 |
View |
Patched-1 |
PTCH1 |
Protein patched homolog 1 |
prognosis(unfavorable) |
30521558 |
View |
PR |
Progesterone receptor |
Progesterone receptor |
diagnosis |
34418427 |
View |
Jag1 |
N/A |
N/A |
prognosis(unfavorable) |
30521558 |
View |
MMR |
N/A |
N/A |
prognosis(unfavorable) |
30521558 |
View |
CA125 |
Mucin 16, cell surface associated |
N/A |
diagnosis |
30508211 |
View |
endoglin |
Endoglin |
Endoglin |
prognosis(unfavorable) |
30479213 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis |
30414437 |
View |
MMP20 |
matrix metallopeptidase 20 |
N/A |
prognosis(unfavorable) |
30377136 |
View |
ALDH1 |
aldehyde dehydrogenase 1 family member A1 |
Aldehyde dehydrogenase 1A1 |
prognosis(unfavorable) |
30372483 |
View |
CD44 |
CD44 molecule (Indian blood group) |
CD44 antigen |
prognosis(unfavourable) |
30372483 |
View |
ALDH1 |
aldehyde dehydrogenase 1 family member A1 |
Aldehyde dehydrogenase 1A1 |
treatment(therapeutic target) |
30372483 |
View |
CD44 |
CD44 molecule (Indian blood group) |
CD44 antigen |
treatment(therapeutic target) |
30372483 |
View |
LCOR |
Ligand dependent nuclear receptor corepressor |
Ligand-dependent corepressor |
prognosis |
34410950 |
View |
API |
N/A |
N/A |
treatment |
30314462 |
View |
PD-1 |
programmed cell death 1 |
Programmed cell death protein 1 |
treatment |
30134343 |
View |
PD-L1 |
programmed cell death 1 |
Programmed cell death 1 ligand 1 |
treatment |
30134343 |
View |
PD-L2 |
CD274 molecule |
N/A |
treatment |
30134343 |
View |
MACC1 |
MET transcriptional regulator MACC1 |
N/A |
diagnosis |
29984790 |
View |
MACC1 |
MET transcriptional regulator MACC1 |
N/A |
diagnosis |
29984790 |
View |
c-Myc |
MYC proto-oncogene, bHLH transcription factor |
Myc proto-oncogene protein |
diagnosis |
29984790 |
View |
c-Myc |
MYC proto-oncogene, bHLH transcription factor |
Myc proto-oncogene protein |
diagnosis |
29984790 |
View |
L1CAM |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
prognosis(unfavorable) |
29980240 |
View |
GLP-1R |
glucagon like peptide 1 receptor |
N/A |
prognosis |
29907137 |
View |
LCOR |
Ligand dependent nuclear receptor corepressor |
Ligand-dependent corepressor |
diagnosis |
34410950 |
View |
GLP-1R |
glucagon like peptide 1 receptor |
N/A |
treatment |
29907137 |
View |
ProGRP |
Gastrin releasing peptide receptor |
N/A |
diagnosis |
29898448 |
View |
PR |
Progesterone receptor |
Progesterone receptor |
treatment |
29869299 |
View |
AR |
androgen receptor |
Androgen receptor |
treatment |
29869299 |
View |
ER-alpha |
Estrogen receptor 1 |
Estrogen receptor |
treatment |
29869299 |
View |
PR |
Progesterone receptor |
Progesterone receptor |
prognosis(favorable) |
29869299 |
View |
AR |
androgen receptor |
Androgen receptor |
prognosis(favorable) |
29869299 |
View |
ER-alpha |
Estrogen receptor 1 |
Estrogen receptor |
prognosis(favorable) |
29869299 |
View |
PIR2 |
N/A |
N/A |
treatment |
29724995 |
View |
BMP |
bone morphogenetic protein 2 |
Bone morphogenetic protein 2 |
treatment(therapeutic target) |
34360647 |
View |
RNF144B |
ring finger protein 144B |
E3 ubiquitin-protein ligase RNF144B |
treatment |
29724995 |
View |
DFF40 |
DNA fragmentation factor subunit beta |
N/A |
prognosis(unfavorable) |
29653556 |
View |
DFF40 |
DNA fragmentation factor subunit beta |
N/A |
prognosis(unfavorable) |
29653556 |
View |
BCL2 |
B-cell lymphoma 2 protein |
N/A |
prognosis(unfavorable) |
29653556 |
View |
BCL2 |
B-cell lymphoma 2 protein |
N/A |
prognosis(unfavorable) |
29653556 |
View |
CC3 |
Caspase 3 |
N/A |
prognosis(unfavorable) |
29626374 |
View |
PD-L1 |
CD274 molecule |
Programmed cell death 1 ligand 1 |
prognosis(unfavorable) |
29572029 |
View |
PD-L1 |
CD274 molecule |
Programmed cell death 1 ligand 1 |
prognosis(unfavorable) |
29572029 |
View |
CD8 |
CD8a molecule |
T-cell surface glycoprotein CD8 alpha chain |
prognosis(unfavorable) |
29572029 |
View |
TRIM44 |
tripartite motif containing 44 |
N/A |
prognosis(unfavorable) |
29526558 |
View |
BMP |
bone morphogenetic protein 7 |
Bone morphogenetic protein 7 |
treatment(therapeutic target) |
34360647 |
View |
visfatin |
nicotinamide phosphoribosyltransferase |
N/A |
prognosis(unfavorable) |
29516012 |
View |
UCHL1 |
ubiquitin C-terminal hydrolase L1 |
N/A |
prognosis(unfavorable) |
29489474 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
prognosis(unfavorable) |
29463191 |
View |
mPRβ |
progestin and adipoQ receptor family member 8 |
Membrane progestin receptor beta |
prognosis(favorable) |
29353001 |
View |
mPRγ |
Progestin and adipoQ receptor family member 6 |
Membrane progestin receptor delta |
prognosis(favorable) |
29353001 |
View |
CaSR |
calcium sensing receptor |
N/A |
prognosis(predictor for endometrial cancer progression) |
29348629 |
View |
CIP2A |
Cellular inhibitor of PP2A |
N/A |
treatment(therapeutic target) |
29274810 |
View |
CIP2A |
Cellular inhibitor of PP2A |
N/A |
treatment(therapeutic target) |
29274810 |
View |
HER2 |
Cellular inhibitor of PP2A |
N/A |
treatment(benefit of anti-HER2 treatments) |
29169184 |
View |
cancer antigen 15-3 |
MUC1 |
Mucin-1 |
diagnosis(identify high-risk patients) |
29114696 |
View |
SOX17 |
SRY-box transcription factor 17 |
Transcription factor SOX-17 |
prognosis(favorable) |
34339705 |
View |
Asparaginase-like protein 1 |
asparaginase and isoaspartyl peptidase 1 |
N/A |
prognosis(unfavorable) |
29096882 |
View |
IRAK1 |
N/A |
N/A |
treatment(therapeutic target) |
28980703 |
View |
cyclin D1 |
cyclin D1 |
N/A |
prognosis(unfavorable) |
28965628 |
View |
SUSD2 |
sushi domain containing 2 |
N/A |
treatment(chemotherapeutic target) |
28841682 |
View |
NTSR1 |
neurotensin receptor 1 |
N/A |
prognosis(unfavorable) |
28836043 |
View |
CA125 |
Mucin 16, cell surface associated |
N/A |
prognosis(unfavorable) |
28800309 |
View |
CD133 |
Prominin 1 |
Prominin-1 |
prognosis(favorable) |
28794448 |
View |
L1CAM |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
prognosis(predicts lymph node metastases) |
28751757 |
View |
L1CAM |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
prognosis(predicts lymph node metastases) |
28751757 |
View |
IFITM1 |
interferon induced transmembrane protein 1 |
N/A |
diagnosis |
28700435 |
View |
GABPA |
GA binding protein transcription factor subunit alpha |
GA-binding protein alpha chain |
prognosis(unfavorable) |
34306255 |
View |
GalNAc-T6 |
polypeptide N-acetylgalactosaminyltransferase 6 |
N/A |
diagnosis(better histological grade) |
28668893 |
View |
NAV2 |
Neuron navigator 2 |
N/A |
prognosis(unfavorable) |
28643014 |
View |
NAV2 |
Neuron navigator 2 |
N/A |
prognosis(unfavorable) |
28643014 |
View |
CCND2 |
Cyclin D2 |
N/A |
prognosis(favorable) |
28643014 |
View |
CCND2 |
Cyclin D2 |
N/A |
prognosis(favorable) |
28643014 |
View |
YKL-40 |
Chitinase 3 like 1 |
N/A |
prognosis(unfavorable) |
28624692 |
View |
CA125 |
Mucin 16, cell surface associated |
N/A |
prognosis(unfavorable) |
28624692 |
View |
DJ-1 |
Parkinsonism associated deglycase |
N/A |
diagnosis(high-risk endometrial cancer patients) |
28618925 |
View |
EMP2 |
Epithelial membrane protein 2 |
N/A |
treatment(reducing endometrial cancer stem cells) |
28604744 |
View |
SerpinE2 |
Serpin family E member 2 |
N/A |
prognosis(unfavorable) |
28453461 |
View |
TET1 |
Tet methylcytosine dioxygenase 1 |
Methylcytosine dioxygenase TET1 |
diagnosis |
34731191 |
View |
GABPA |
GA binding protein transcription factor subunit alpha |
GA-binding protein alpha chain |
treatment(therapeutic target) |
34306255 |
View |
EZH2 |
Enhancer of zeste 2 polycomb repressive complex 2 subunit |
Histone-lysine N-methyltransferase EZH2 |
treatment(therapeutic target) |
28418882 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
prognosis(unfavorable) |
28401338 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
prognosis(unfavorale) |
28382859 |
View |
DJ-1 |
Parkinsonism associated deglycase |
N/A |
diagnosis |
28374920 |
View |
DJ-1 |
Parkinsonism associated deglycase |
N/A |
diagnosis |
28374920 |
View |
androgen receptor (AR) |
androgen receptor |
Androgen receptor |
prognosis(favorable) |
28277313 |
View |
galectin-3 |
Galectin 3 |
Galectin-3 |
prognosis(unfavorable) |
28215640 |
View |
galectin-3 |
Galectin 3 |
Galectin-3 |
prognosis(unfavorable) |
28215640 |
View |
SHP-1 |
Protein tyrosine phosphatase non-receptor type 6 |
Tyrosine-protein phosphatase non-receptor type 6 |
prognosis(unfavorable) |
28187032 |
View |
SHP-1 |
Protein tyrosine phosphatase non-receptor type 6 |
Tyrosine-protein phosphatase non-receptor type 6 |
prognosis(unfavorable) |
28187032 |
View |
ZIC2 |
Zic family member 2 |
Zinc finger protein ZIC 2 |
treatment(therapeutic target) |
34278490 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
diagnosis |
28155970 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
diagnosis |
28155970 |
View |
p16 |
Cyclin dependent kinase inhibitor 2A |
Tumor suppressor ARF |
diagnosis |
28155970 |
View |
p16 |
Cyclin dependent kinase inhibitor 2A |
Tumor suppressor ARF |
diagnosis |
28155970 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis |
28098927 |
View |
NF-YAs |
Nuclear transcription factor Y subunit alpha |
Nuclear transcription factor Y subunit alpha |
diagnosis(identify G1 ECs patients with risk of recurrence) |
27974701 |
View |
lamin A |
lamin A/C |
Prelamin-A/C |
diagnosis(identify G1 ECs patients with risk of recurrence) |
27974701 |
View |
S100P |
S100 calcium binding protein P |
Protein S100-P |
diagnosis(quamous cell and adenosquamous carcinoma subtypes of endometrial cancer) |
27918216 |
View |
S100P |
S100 calcium binding protein P |
Protein S100-P |
treatment(drug therapeutic target,quamous cell and adenosquamous carcinoma subtypes of endometrial cancer ) |
27918216 |
View |
p16 |
Cyclin dependent kinase inhibitor 2A |
Tumor suppressor ARF |
diagnosis |
27902476 |
View |
ARID1A |
AT-rich interaction domain 1A |
AT-rich interactive domain-containing protein 1A |
prognosis(favorable) |
34257552 |
View |
p16 |
Cyclin dependent kinase inhibitor 2A |
Tumor suppressor ARF |
diagnosis |
27902476 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
prognosis(unfavorable) |
27892774 |
View |
ALCAM |
Activated leukocyte cell adhesion molecule |
CD166 antigen |
prognosis(unfavorable) |
27873306 |
View |
L1CAM |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
prognosis(unfavorable) |
27648714 |
View |
HIF-1α |
hypoxia inducible factor 1 subunit alpha |
Hypoxia-inducible factor 1-alpha inhibitor |
prognosis(unfavorable) |
27634881 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis |
27562869 |
View |
CA125 |
Mucin 16, cell surface associated |
N/A |
diagnosis |
27562869 |
View |
CA724 |
N/A |
N/A |
diagnosis |
27562869 |
View |
CA19-9 |
N/A |
N/A |
diagnosis |
27562869 |
View |
CA-125 |
Mucin 16, cell surface associated |
N/A |
prognosis(unfavorable) |
27549092 |
View |
ARID1A |
AT-rich interaction domain 1A |
AT-rich interactive domain-containing protein 1A |
prognosis(favorable) |
34257552 |
View |
GGT |
gamma-glutamyltransferase 1 |
Glutathione hydrolase 1 proenzyme |
prognosis(favorable) |
27512000 |
View |
L1CAM |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
prognosis(unfavorable) |
27488577 |
View |
Fzd2 |
Frizzled class receptor 2 |
Frizzled-2 |
treatment(therapeutic target) |
27373314 |
View |
IL-31 |
interleukin 31 |
Interleukin-31 |
diagnosis |
27340318 |
View |
IL-33 |
interleukin 33 |
Interleukin-33 |
diagnosis |
27340318 |
View |
HE-4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis |
27268621 |
View |
HE-4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis |
27268621 |
View |
SIX1 |
SIX homeobox 1 |
Homeobox protein SIX1 |
diagnosis |
27259717 |
View |
PAX1 |
paired box 1 |
Paired box protein Pax-1 |
prognosis(favorable) |
27226215 |
View |
PAX1 |
paired box 1 |
Paired box protein Pax-1 |
diagnosis |
27226215 |
View |
Galectin-3 |
Galectin 3 |
Galectin-3 |
prognosis |
34241773 |
View |
ERRα |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
treatment(therapeutic target) |
27153547 |
View |
HDACs 1 |
Histone deacetylase 1 |
Histone deacetylase 1 |
treatment(therapeutic target) |
27127168 |
View |
HDACs 4 |
histone deacetylase 4 |
Histone deacetylase 4 |
treatment(therapeutic target) |
27127168 |
View |
HDACs 6 |
Histone deacetylase 6 |
Histone deacetylase 6 |
treatment(therapeutic target) |
27127168 |
View |
HDACs 7 |
Histone deacetylase 7 |
Histone deacetylase 7 |
treatment(therapeutic target) |
27127168 |
View |
isoform B of progesterone receptor |
N/A |
N/A |
prognosis(predicted faster remission) |
34162378 |
View |
HDACs 8 |
Histone deacetylase 8 |
Histone deacetylase 8 |
treatment(therapeutic target) |
27127168 |
View |
IFITM1 |
interferon induced transmembrane protein 1 |
Interferon-induced transmembrane protein 1 |
diagnosis(absence of invasion) |
27124937 |
View |
USP14 |
ubiquitin specific peptidase 14 |
Ubiquitin carboxyl-terminal hydrolase 14 |
prognosis(unfavorable) |
27121063 |
View |
clusterin |
clusterin |
Clusterin |
diagnosis |
27079858 |
View |
survivin |
Baculoviral IAP repeat containing 5 |
Baculoviral IAP repeat-containing protein 5 |
prognosis(unfavorable) |
27079211 |
View |
survivin |
Baculoviral IAP repeat containing 5 |
Baculoviral IAP repeat-containing protein 5 |
treatment(therapeutic target) |
27079211 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis |
27039795 |
View |
CD103 |
integrin subunit alpha E |
Integrin alpha-E |
prognosis(favorable) |
27038842 |
View |
SLUG |
snail family transcriptional repressor 2 |
Zinc finger protein SNAI2 |
prognosis(unfavorable) |
27003026 |
View |
SLUG |
snail family transcriptional repressor 2 |
Zinc finger protein SNAI2 |
treatment(therapeutic target) |
27003026 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
prognosis(unfavorable) |
34109467 |
View |
CD169 |
sialic acid binding Ig like lectin 1 |
Sialoadhesin |
treatment(monitoring anti-tumor immunity) |
26991548 |
View |
MIF |
macrophage migration inhibitory factor |
Macrophage migration inhibitory factor |
diagnosis |
26985869 |
View |
c-erbB-2 |
Erb-b2 receptor tyrosine kinase 2 |
Receptor tyrosine-protein kinase erbB-2 |
diagnosis |
26985869 |
View |
S18-2 |
Presenilin 1 |
Presenilin-1 |
prognosis |
26959119 |
View |
E2F1 |
E2F transcription factor 1 |
Transcription factor E2F1 |
prognosis |
26959119 |
View |
Estrogen receptor-alpha |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
diagnosis(higher grade and advanced stage ) |
26957478 |
View |
CA-125 |
Mucin 16, cell surface associated |
N/A |
diagnosis(predicate myometrial Invasion) |
26925634 |
View |
L1CAM |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
prognosis(unfavorable) |
26891628 |
View |
NUCB2 |
Nucleobindin 2 |
Nucleobindin-2 |
prognosis(unfavorable) |
26842712 |
View |
Nup88 |
nucleoporin 88 |
Nuclear pore complex protein Nup88 |
diagnosis(pre-malignant lesions and early-stage) |
26839161 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
prognosis(unfavorable) |
34109467 |
View |
Nup88 |
nucleoporin 88 |
Nuclear pore complex protein Nup88 |
diagnosis(pre-malignant lesions and early-stage) |
26839161 |
View |
L1CAM |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
prognosis(unfavorable) |
26743472 |
View |
GAL-3 |
Galectin 3 |
Galectin-3 |
prognosis(unfavorable) |
26708131 |
View |
CRIP-1 |
cysteine rich protein 1 |
Cysteine-rich protein 1 |
prognosis(unfavorable) |
26708131 |
View |
NRP-1 |
Neuropilin 1 |
Neuropilin-1 |
prognosis(predicator of metastatic) |
26701889 |
View |
NRP-1 |
Neuropilin 1 |
Neuropilin-1 |
prognosis(predicator of metastatic) |
26701889 |
View |
CXCR4 |
C-X-C motif chemokine receptor 4 |
C-X-C chemokine receptor type 4 |
treatment(therapeutic target) |
26678890 |
View |
CXCR7 |
Atypical chemokine receptor 3 |
Atypical chemokine receptor 3 |
treatment(therapeutic target) |
26678890 |
View |
STN |
CD44 molecule (Indian blood group) |
CD44 antigen |
prognosis(unfavorable) |
26678075 |
View |
CD44 |
CD44 molecule (Indian blood group) |
CD44 antigen |
prognosis(favorable) |
26608413 |
View |
ALDH1 |
aldehyde dehydrogenase 1 family member A1 |
Aldehyde dehydrogenase 1A1 |
prognosis(progression of premalignan) |
34099751 |
View |
CD133 |
Prominin 1 |
Prominin-1 |
prognosis(favorable) |
26608413 |
View |
HE-4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis(discriminating early and advanced stages) |
26607777 |
View |
YKL-40 |
Chitinase 3 like 1 |
N/A |
diagnosis(discriminating early and advanced stages) |
26607777 |
View |
TOP2A |
DNA topoisomerase II alpha |
DNA topoisomerase 2-alpha |
prognosis(unfavorable) |
26588239 |
View |
TOP2A |
DNA topoisomerase II alpha |
DNA topoisomerase 2-alpha |
treatment(receiving adjuvant taxane-platinum regimens) |
26588239 |
View |
CDK4 |
cyclin dependent kinase 4 |
Cyclin-dependent kinase 4 |
prognosis(recurrence) |
26554657 |
View |
CDK6 |
cyclin dependent kinase 6 |
N/A |
treatment(chemosensitive) |
26554657 |
View |
CDK4 |
cyclin dependent kinase 4 |
Cyclin-dependent kinase 4 |
prognosis(recurrence) |
26554657 |
View |
CDK6 |
cyclin dependent kinase 6 |
N/A |
treatment(chemosensitive) |
26554657 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
prognosis(unfavorable) |
26539494 |
View |
RAGE |
indoleamine 2,3-dioxygenase 1 |
N/A |
diagnosis(immune modulatory factor) |
33922995 |
View |
ANXA2 |
annexin A2 |
Annexin A2 |
prognosis(unfavorable) |
26362938 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
prognosis(unfavorable) |
26362938 |
View |
ANXA2 |
annexin A2 |
Annexin A2 |
prognosis(unfavorable) |
26362938 |
View |
TATI |
N/A |
N/A |
prognosis(recurrence and distant metastasis) |
26350184 |
View |
SPAG9 |
sperm associated antigen 9 |
C-Jun-amino-terminal kinase-interacting protein 4 |
treatment(progestin treatment) |
26334303 |
View |
SPAG9 |
sperm associated antigen 9 |
C-Jun-amino-terminal kinase-interacting protein 4 |
treatment(progestin treatment) |
26334303 |
View |
SPAG9 |
sperm associated antigen 9 |
C-Jun-amino-terminal kinase-interacting protein 4 |
prognosis(progestin treatment) |
26334303 |
View |
SPAG9 |
sperm associated antigen 9 |
C-Jun-amino-terminal kinase-interacting protein 4 |
prognosis(progestin treatment) |
26334303 |
View |
ATAD2 |
ATPase family AAA domain containing 2 |
ATPase family AAA domain-containing protein 2 |
prognosis(unfavorable) |
26308378 |
View |
PGI |
GPI |
Glucose-6-phosphate isomerase |
treatment(therapeutic target) |
26308071 |
View |
IFITM1 |
interferon induced transmembrane protein 1 |
Methylcytosine dioxygenase TET1 |
diagnosis |
34556086 |
View |
IDO1 |
indoleamine 2,3-dioxygenase 1 |
N/A |
diagnosis(immune modulatory factor) |
33922995 |
View |
PGI |
GPI |
Glucose-6-phosphate isomerase |
treatment(therapeutic target) |
26308071 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
|
26265413 |
View |
CDC20 |
Cell division cycle 20 |
Cell division cycle protein 20 homolog |
prognosis(unfavorable) |
26245990 |
View |
CDC20 |
Cell division cycle 20 |
Cell division cycle protein 20 homolog |
treatment(therapeutic target) |
26245990 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis(predictor in distinguishing the high-risk patients) |
26223178 |
View |
COX-2 |
Mitochondrially encoded cytochrome c oxidase II |
Cytochrome c oxidase subunit 2 |
prognosis(does not seem to be associated with prognostic factors or survival) |
26222488 |
View |
AMF |
GPI |
Glucose-6-phosphate isomerase |
prognosis(unfavorable) |
26201353 |
View |
AMF |
GPI |
Glucose-6-phosphate isomerase |
treatment(therapeutic target) |
26201353 |
View |
Musashi-1 protein |
Musashi RNA binding protein 1 |
RNA-binding protein Musashi homolog 1 |
prognosis(unfavorable) |
26191146 |
View |
LSD1 |
Lysine demethylase 1A |
Lysine-specific histone demethylase 1A |
prognosis(unfavorable) |
26166558 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
33858677 |
View |
TILs |
N/A |
N/A |
prognosis(unfavorable) |
26111272 |
View |
CA125 |
Mucin 16, cell surface associated |
N/A |
diagnosis(evaluate adnexal involement, lymph node metastasis) |
25964114 |
View |
Enolase-1 |
enolase 1 |
Alpha-enolase |
treatment(therapeutic target) |
25951350 |
View |
Enolase-1 |
enolase 1 |
Alpha-enolase |
prognosis(unfavorable) |
25951350 |
View |
ANCCA |
KH RNA binding domain containing, signal transduction associated 1 |
ATPase family AAA domain-containing protein 3A |
prognosis(unfavorable) |
25934333 |
View |
Sam68 |
KH RNA binding domain containing, signal transduction associated 1 |
KH domain-containing, RNA-binding, signal transduction-associated protein 1 |
prognosis(unfavorable) |
25874492 |
View |
ASRGL1 |
asparaginase and isoaspartyl peptidase 1 |
Isoaspartyl peptidase/L-asparaginase |
prognosis(unfavorable) |
25858696 |
View |
ASRGL1 |
asparaginase and isoaspartyl peptidase 1 |
Isoaspartyl peptidase/L-asparaginase |
prognosis(unfavorable) |
25858696 |
View |
Ca125 |
Mucin 16, cell surface associated |
N/A |
prognosis(unfavorable) |
25731151 |
View |
Tag72 |
N/A |
N/A |
prognosis(unfavorable) |
25731151 |
View |
L1CAM |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
prognosis(unfavorable) |
33858677 |
View |
G9a |
euchromatic histone lysine methyltransferase 2 |
Histone-lysine N-methyltransferase EHMT2 |
treatment(therapeutic target) |
25613390 |
View |
ARID1A |
AT-rich interaction domain 1A |
AT-rich interactive domain-containing protein 1A |
diagnosis(peritoneal washings to confirm malignancy) |
25557364 |
View |
Cyclin D1 |
cyclin D1 |
G1/S-specific cyclin-D1 |
diagnosis(endometrial carcinogenesis and tumor cell proliferation) |
25511212 |
View |
Ki67 |
marker of proliferation Ki-67 |
Proliferation marker protein Ki-67 |
diagnosis(endometrial carcinogenesis and tumor cell proliferation) |
25511212 |
View |
POLE |
N/A |
N/A |
prognosis(favorable) |
25505230 |
View |
RAB8A |
RAB8A, member RAS oncogene family |
Ras-related protein Rab-8A |
diagnosis |
25477298 |
View |
HAND2 |
heart and neural crest derivatives expressed 2 |
Heart- and neural crest derivatives-expressed protein 2 |
diagnosis |
25473755 |
View |
HAND2 |
heart and neural crest derivatives expressed 2 |
Heart- and neural crest derivatives-expressed protein 2 |
diagnosis |
25473755 |
View |
HAND2 |
heart and neural crest derivatives expressed 2 |
Heart- and neural crest derivatives-expressed protein 2 |
diagnosis |
25473755 |
View |
CA125 |
Mucin 16, cell surface associated |
N/A |
prognosis(unfavorable) |
25423695 |
View |
ER |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
prognosis(unfavorable) |
33858677 |
View |
HABP1 |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta pseudogene 1 |
Complement component 1 Q subcomponent-binding protein, mitochondrial |
prognosis(unfavorable) |
25355598 |
View |
SATB1 |
SATB homeobox 1 |
DNA-binding protein SATB1 |
prognosis(unfavorable) |
25347096 |
View |
SATB1 |
SATB homeobox 1 |
DNA-binding protein SATB1 |
prognosis(unfavorable) |
25347096 |
View |
cyclin B |
cyclin B1 |
G2/mitotic-specific cyclin-B1 |
prognosis(unfavorable) |
25315186 |
View |
MSH2 |
MutS homolog 2 |
DNA mismatch repair protein Msh2 |
prognosis(unfavorable) |
25310854 |
View |
MLH1 |
MLH1 |
DNA mismatch repair protein Mlh1 |
prognosis(unfavorable) |
25310854 |
View |
MSH6 |
MutS homolog 6 |
DNA mismatch repair protein Msh6 |
prognosis(unfavorable) |
25310854 |
View |
PMS2 |
PMS1 homolog 2, mismatch repair system component |
Mismatch repair endonuclease PMS2 |
prognosis(unfavorable) |
25310854 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
diagnosis |
25282036 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
diagnosis |
25282036 |
View |
PR |
Progesterone receptor |
Progesterone receptor |
prognosis(unfavorable) |
33858677 |
View |
IMP2 |
inner mitochondrial membrane peptidase subunit 2 |
Mitochondrial inner membrane protease subunit 2 |
diagnosis |
25282036 |
View |
IMP2 |
inner mitochondrial membrane peptidase subunit 2 |
Mitochondrial inner membrane protease subunit 2 |
diagnosis |
25282036 |
View |
IMP3 |
IMP U3 small nucleolar ribonucleoprotein 3 |
U3 small nucleolar ribonucleoprotein protein IMP3 |
diagnosis |
25282036 |
View |
IMP3 |
IMP U3 small nucleolar ribonucleoprotein 3 |
U3 small nucleolar ribonucleoprotein protein IMP3 |
diagnosis |
25282036 |
View |
cyclin E1 |
Cyclin E1 |
G1/S-specific cyclin-E1 |
diagnosis |
25282036 |
View |
cyclin E1 |
Cyclin E1 |
G1/S-specific cyclin-E1 |
diagnosis |
25282036 |
View |
HMGA2 |
High mobility group AT-hook 2 |
High mobility group protein HMGI-C |
diagnosis |
25282036 |
View |
HMGA2 |
High mobility group AT-hook 2 |
High mobility group protein HMGI-C |
diagnosis |
25282036 |
View |
FolR1 |
folate receptor alpha |
Folate receptor alpha |
diagnosis |
25282036 |
View |
FolR1 |
folate receptor alpha |
Folate receptor alpha |
diagnosis |
25282036 |
View |
mesothelin |
mesothelin |
Mesothelin |
prognosis(unfavorable) |
33832498 |
View |
p16 |
Cyclin dependent kinase inhibitor 2A |
Tumor suppressor ARF |
diagnosis |
25282036 |
View |
p16 |
Cyclin dependent kinase inhibitor 2A |
Tumor suppressor ARF |
diagnosis |
25282036 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
diagnosis |
25282036 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
diagnosis |
25282036 |
View |
estrogen receptor |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
diagnosis |
25282036 |
View |
estrogen receptor |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
diagnosis |
25282036 |
View |
estrogen receptor |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
diagnosis |
25282036 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
diagnosis |
25282036 |
View |
CRHR1 |
corticotropin releasing hormone receptor 1 |
Corticotropin-releasing factor receptor 1 |
prognosis(unfavorable) |
25254562 |
View |
ANXA2 |
annexin A2 |
Annexin A2 |
prognosis(recurrent) |
25219463 |
View |
mesothelin |
mesothelin |
Mesothelin |
prognosis(unfavorable) |
33832498 |
View |
ANXA2 |
annexin A2 |
Annexin A2 |
prognosis(recurrent) |
25219463 |
View |
ANXA2 |
annexin A2 |
Annexin A2 |
prognosis(recurrent) |
25219463 |
View |
ANXA2 |
annexin A2 |
Annexin A2 |
prognosis(recurrent) |
25219463 |
View |
IgA autoantibody against DLDDLD(dihydrolipoamide dehydrogenase) |
N/A |
N/A |
diagnosis |
25202086 |
View |
WT-1 |
WT1 transcription factor |
Wilms tumor protein |
prognosis(unfavorable) |
25033726 |
View |
HER-2/neu |
erb-b2 receptor tyrosine kinase 2 |
N/A |
prognosis |
25022554 |
View |
Yes-associated protein (YAP) |
Yes1 associated transcriptional regulator |
Transcriptional coactivator YAP1 |
prognosis(unfavorable) |
24972085 |
View |
Yes-associated protein (YAP) |
Yes1 associated transcriptional regulator |
Transcriptional coactivator YAP1 |
treatment(therapeutic targett/predict radiation sensitivity) |
24972085 |
View |
Rictor |
RPTOR independent companion of MTOR complex 2 |
Rapamycin-insensitive companion of mTOR |
prognosis(unfavorable) |
24966915 |
View |
Rictor |
RPTOR independent companion of MTOR complex 2 |
Rapamycin-insensitive companion of mTOR |
prognosis(unfavorable) |
24966915 |
View |
CA125 |
Mucin 16, cell surface associated |
N/A |
prognosis(unfavorable) |
33832498 |
View |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
Cytochrome P450 1A1 |
treatment(chemotherapeutic targetts) |
24957043 |
View |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
Cytochrome P450 1B1 |
treatment(chemotherapeutic targetts) |
24957043 |
View |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
Cytochrome P450 1A1 |
treatment(chemotherapeutic targetts) |
24957043 |
View |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
Cytochrome P450 1B1 |
treatment(chemotherapeutic targetts) |
24957043 |
View |
KPNA2 |
karyopherin subunit alpha 2 |
Importin subunit alpha-1 |
diagnosis(identification of patients who need more aggressive treatment regimens) |
24930886 |
View |
MRE11 |
MRE11 homolog, double strand break repair nuclease |
Double-strand break repair protein MRE11 |
treatment(sensitivity to PARP-inhibitor) |
24927325 |
View |
HSF1 |
heat shock transcription factor 1 |
Heat shock factor protein 1 |
prognosis(unfavorable) |
24853175 |
View |
FOXA1 |
forkhead box A1 |
Hepatocyte nuclear factor 3-alpha |
prognosis(unfavorable) |
24849812 |
View |
ER |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
prognosis(favorable) |
24762589 |
View |
PR |
Progesterone receptor |
Progesterone receptor |
prognosis(favorable) |
24762589 |
View |
L1CAM |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
prognosis(unfavorable) |
33787629 |
View |
P53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(favorable) |
24762589 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
prognosis(favorable) |
24762589 |
View |
ER |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
prognosis(unfavorable) |
24762589 |
View |
PR |
Progesterone receptor |
Progesterone receptor |
prognosis(unfavorable) |
24762589 |
View |
P53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
24762589 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
prognosis(unfavorable) |
24762589 |
View |
S100A4 |
S100 calcium binding protein A4 |
Protein S100-A4 |
prognosis(unfavorable) |
24756855 |
View |
HDGF |
Heparin binding growth factor |
Hepatoma-derived growth factor |
prognosis(unfavorable) |
24692842 |
View |
MMP2 |
Matrix metallopeptidase 2 |
72 kDa type IV collagenase |
diagnosis |
24670463 |
View |
CA 125 |
Mucin 16, cell surface associated |
N/A |
prognosis(unfavorable) |
24659664 |
View |
MYBL2 |
MYB proto-oncogene like 2 |
Transcriptional activator Myb |
prognosis(unfavorable) |
33782625 |
View |
DJ-1 |
Parkinsonism associated deglycase |
N/A |
diagnosis |
24614826 |
View |
DJ-1 |
Parkinsonism associated deglycase |
N/A |
diagnosis |
24614826 |
View |
DJ-1 |
Parkinsonism associated deglycase |
N/A |
diagnosis |
24614826 |
View |
DJ-1 |
Parkinsonism associated deglycase |
N/A |
diagnosis |
24614826 |
View |
TNFAIP8 |
TNF alpha induced protein 8 |
Tumor necrosis factor alpha-induced protein 8 |
prognosis(unfavorable) |
24590269 |
View |
stathmin |
Stathmin 1 |
Stathmin |
treatment(paclitaxel treatment) |
24587245 |
View |
SPAG9 |
sperm associated antigen 9 |
C-Jun-amino-terminal kinase-interacting protein 4 |
diagnosis |
24460345 |
View |
VEGF |
vascular endothelial growth factor A |
Vascular endothelial growth factor A |
diagnosis(predictive metastases) |
24420153 |
View |
GdA |
guanine deaminase |
Guanine deaminase |
prognosis(unfavorable) |
24377825 |
View |
maspin |
serpin family B member 5 |
Serpin B5 |
diagnosis |
24346847 |
View |
CD10 |
membrane metalloendopeptidase |
Neprilysin |
diagnosis |
34556086 |
View |
CHK1 |
Checkpoint kinase 1 |
Serine/threonine-protein kinase Chk1 |
prognosis(favorable) |
33754208 |
View |
maspin |
serpin family B member 5 |
Serpin B5 |
diagnosis |
24346847 |
View |
estrogen receptor-α |
estrogen receptor 1 |
Estrogen receptor |
prognosis(unfavorable) |
24335662 |
View |
CD117 |
KIT proto-oncogene, receptor tyrosine kinase |
Mast/stem cell growth factor receptor Kit |
prognosis(unfavorable) |
24333732 |
View |
CD117 |
KIT proto-oncogene, receptor tyrosine kinase |
Mast/stem cell growth factor receptor Kit |
treatment(therapeutic target(therapeutic targeting of the SCF/CD117 axis)) |
24333732 |
View |
tumor-associated carbohydrate antigen sTn |
N/A |
N/A |
diagnosis |
24316923 |
View |
URI |
URI1 prefoldin like chaperone |
Unconventional prefoldin RPB5 interactor 1 |
diagnosis |
24228101 |
View |
URI |
URI1 prefoldin like chaperone |
Unconventional prefoldin RPB5 interactor 1 |
prognosis(high-grade endometrioid adenocarcinomas ) |
24228101 |
View |
E-Cadherin |
cadherin 1 |
Cadherin-1 |
prognosis(favorable) |
24222154 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
prognosis(unfavorable) |
24211402 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
prognosis(unfavorable) |
24211402 |
View |
FBXW7 |
F-box and WD repeat domain containing 7 |
F-box/WD repeat-containing protein 7 |
prognosis(favorable) |
33754208 |
View |
MAI |
N/A |
N/A |
prognosis(predictive of recurrence) |
24146786 |
View |
PPH3 |
N/A |
N/A |
prognosis(predictive of recurrence) |
24146786 |
View |
Ki-67 |
marker of proliferation Ki-67 |
Proliferation marker protein Ki-67 |
prognosis(predictive of recurrence) |
24146786 |
View |
napsin A |
Napsin A aspartic peptidase |
Napsin-A |
diagnosis |
24145649 |
View |
napsin A |
Napsin A aspartic peptidase |
Napsin-A |
diagnosis |
24145649 |
View |
napsin A |
Napsin A aspartic peptidase |
Napsin-A |
diagnosis |
24145649 |
View |
Pin1 |
Peptidylprolyl cis/trans isomerase, NIMA-interacting 1 |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 |
prognosis(prognostic marker as PR in patients with endometrial cancer) |
24067230 |
View |
Pin1 |
Peptidylprolyl cis/trans isomerase, NIMA-interacting 1 |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 |
prognosis(prognostic marker as PR in patients with endometrial cancer) |
24067230 |
View |
albumin |
albumin |
Albumin |
prognosis(unfavorable) |
24011381 |
View |
CyclinD1 |
cyclin D1 |
G1/S-specific cyclin-D1 |
prognosis(unfavorable) |
23947899 |
View |
PPP2R1B |
protein phosphatase 2 scaffold subunit Abeta |
PP2A subunit A isoform PR65-beta
PP2A subunit A isoform R1-beta |
prognosis(favorable) |
33754208 |
View |
ER |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
prognosis(unfavorable) |
23932335 |
View |
PR |
Progesterone receptor |
Progesterone receptor |
prognosis(unfavorable) |
23932335 |
View |
ER |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
prognosis(predicts lymph node metastasis) |
23932335 |
View |
PR |
Progesterone receptor |
Progesterone receptor |
prognosis(predicts lymph node metastasis) |
23932335 |
View |
Ki-67 |
marker of proliferation Ki-67 |
Proliferation marker protein Ki-67 |
prognosis(favorable, select patients
with ESS for fertility-preservation surgery) |
23896713 |
View |
ER |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
prognosis(favorable, select patients
with ESS for fertility-preservation surgery) |
23896713 |
View |
PR |
Progesterone receptor |
Progesterone receptor |
prognosis(favorable, select patients
with ESS for fertility-preservation surgery) |
23896713 |
View |
hPEBP4 |
Phosphatidylethanolamine binding protein 4 |
Phosphatidylethanolamine-binding protein 4 |
treatment |
23818363 |
View |
OATP1B3 |
Solute carrier organic anion transporter family member 1B3 |
Solute carrier organic anion transporter family member 1B3 |
prognosis(favorable, treated with adjuvant TC chemotherapy) |
23782748 |
View |
CTR1 |
solute carrier family 31 member 1 |
High affinity copper uptake protein 1 |
prognosis |
23782748 |
View |
Ki-67 |
marker of proliferation Ki-67 |
Proliferation marker protein Ki-67 |
prognosis |
33714260 |
View |
L1CAM |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
prognosis(unfavorable,, predicting recurrence) |
23781004 |
View |
L1CAM |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
prognosis(unfavorable,, predicting recurrence) |
23781004 |
View |
progesterone receptor |
Progesterone receptor |
Progesterone receptor |
prognosis(unfavorable) |
23777659 |
View |
ProExC |
N/A |
N/A |
diagnosis(differentiating ECA from EMA) |
23719407 |
View |
C2GnT1 |
GCNT1 |
Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase |
prognosis(unfavorable) |
23617619 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
diagnosis |
23613406 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
diagnosis |
23613406 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
prognosis |
23613406 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis |
23613406 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
prognosis |
23583212 |
View |
CEA |
N/A |
N/A |
diagnosis |
33660848 |
View |
CA125 |
Mucin 16, cell surface associated |
N/A |
prognosis |
23583212 |
View |
S38 |
Serine protease 38 |
Serine protease 38 |
diagnosis |
23538402 |
View |
P53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
23524907 |
View |
Visfatin |
nicotinamide phosphoribosyltransferase |
Nicotinamide phosphoribosyltransferase |
prognosis(unfavorable) |
23438672 |
View |
Visfatin |
nicotinamide phosphoribosyltransferase |
Nicotinamide phosphoribosyltransferase |
prognosis(unfavorable) |
23438672 |
View |
hypoxia-inducible factor 1α |
hypoxia inducible factor 1 subunit alpha |
Hypoxia-inducible factor 1-alpha |
diagnosis(aggressive phenotype) |
23372184 |
View |
hypoxia-inducible factor 1α |
hypoxia inducible factor 1 subunit alpha |
Hypoxia-inducible factor 1-alpha |
diagnosis(aggressive phenotype) |
23372184 |
View |
TWIST |
twist family bHLH transcription factor 1 |
Twist-related protein 1 |
diagnosis(aggressive phenotype) |
23372184 |
View |
TWIST |
twist family bHLH transcription factor 1 |
Twist-related protein 1 |
diagnosis(aggressive phenotype) |
23372184 |
View |
E-cadherin |
cadherin 1 |
Cadherin-1 |
diagnosis(aggressive phenotype) |
23372184 |
View |
periostin |
Periostin |
Periostin |
diagnosis |
33660848 |
View |
E-cadherin |
cadherin 1 |
Cadherin-1 |
diagnosis(aggressive phenotype) |
23372184 |
View |
Bub1 |
BUB1 |
Mitotic checkpoint serine/threonine-protein kinase BUB1 |
prognosis(unfavorable) |
23334889 |
View |
Mad2 |
Mitotic arrest deficient 2 |
Mitotic spindle assembly checkpoint protein MAD2A |
prognosis |
23334889 |
View |
Bub1 |
BUB1 |
Mitotic checkpoint serine/threonine-protein kinase BUB1 |
diagnosis |
23334889 |
View |
Mad2 |
Mitotic arrest deficient 2 |
Mitotic spindle assembly checkpoint protein MAD2A |
prognosis |
23334889 |
View |
Bub1 |
BUB1 |
Mitotic checkpoint serine/threonine-protein kinase BUB1 |
diagnosis |
23334889 |
View |
Mad2 |
Mitotic arrest deficient 2 |
Mitotic spindle assembly checkpoint protein MAD2A |
prognosis |
23334889 |
View |
Wnt7a |
Wnt family member 7A |
Protein Wnt-7a |
prognosis(unfavorable) |
23321718 |
View |
ERα |
estrogen receptor 1 |
Estrogen receptor |
prognosis(unfavorable) |
23266443 |
View |
ERβ1 |
N/A |
N/A |
prognosis(unfavorable) |
23266443 |
View |
IDO |
indoleamine 2,3-dioxygenase 1;indoleamine 2,3-dioxygenase 2; |
N/A |
diagnosis |
33660848 |
View |
ERα |
estrogen receptor 1 |
Estrogen receptor |
prognosis(unfavorable) |
23266443 |
View |
ERβ1 |
N/A |
N/A |
prognosis(unfavorable) |
23266443 |
View |
ER-α36 |
Progesterone receptor |
Progesterone receptor |
prognosis(unfavorable) |
23257935 |
View |
ER-α36 |
Progesterone receptor |
Progesterone receptor |
treatment |
23257935 |
View |
ER-α36 |
Progesterone receptor |
Progesterone receptor |
diagnosis |
23257935 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
23221606 |
View |
ki67 |
marker of proliferation Ki-67 |
Proliferation marker protein Ki-67 |
prognosis(unfavorable) |
23221606 |
View |
GRP78 |
heat shock protein family A (Hsp70) member 5 |
Endoplasmic reticulum chaperone BiP |
prognosis(unfavorable) |
23200913 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis |
23179397 |
View |
E-cadherin |
cadherin 1 |
Cadherin-1 |
prognosis(unfavorable) |
23114646 |
View |
CEA |
N/A |
N/A |
diagnosis |
33660848 |
View |
Snail |
snail family transcriptional repressor 1 |
Zinc finger protein SNAI1 |
prognosis(unfavorable) |
23114646 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
prognosis |
23096757 |
View |
ERRγ |
estrogen related receptor gamma |
Estrogen-related receptor gamma |
prognosis(unfavorable) |
23051957 |
View |
ERα |
estrogen receptor 1 |
Estrogen receptor |
prognosis(unfavorable) |
23051957 |
View |
ERRγ |
estrogen related receptor gamma |
Estrogen-related receptor gamma |
treatment |
23051957 |
View |
ERα |
estrogen receptor 1 |
Estrogen receptor |
treatment |
23051957 |
View |
cyclin D1 |
cyclin D1 |
G1/S-specific cyclin-D1 |
diagnosis(indicator of YWHAE-FAM22 ESS) |
22982899 |
View |
YKL-40 |
Chitinase 3 like 1 |
N/A |
diagnosis |
22945838 |
View |
YKL-40 |
Chitinase 3 like 1 |
N/A |
prognosis(unfavorable) |
22945838 |
View |
PKM2 |
pyruvate kinase M1/2 |
Pyruvate kinase PKM |
diagnosis(predict high-risk endometrial carcinoma) |
22889453 |
View |
periostin |
Periostin |
Periostin |
diagnosis |
33660848 |
View |
HSPA5 |
Heat shock protein family A (Hsp70) member 5 |
Endoplasmic reticulum chaperone BiP |
diagnosis(predict high-risk endometrial carcinoma) |
22889453 |
View |
PKM2 |
pyruvate kinase M1/2 |
Pyruvate kinase PKM |
diagnosis(predict high-risk endometrial carcinoma) |
22889453 |
View |
HSPA5 |
Heat shock protein family A (Hsp70) member 5 |
Endoplasmic reticulum chaperone BiP |
diagnosis(predict high-risk endometrial carcinoma) |
22889453 |
View |
MMSET |
nuclear receptor binding SET domain protein 2 |
Endoplasmic reticulum chaperone BiP |
prognosis(unfavorable) |
22886632 |
View |
MMSET |
nuclear receptor binding SET domain protein 2 |
Endoplasmic reticulum chaperone BiP |
prognosis(unfavorable) |
22886632 |
View |
fascin |
Fascin actin-bundling protein 1 |
Fascin |
prognosis(different steps of extracellular matrix invasion) |
22784357 |
View |
fascin |
Fascin actin-bundling protein 1 |
Fascin |
prognosis(different steps of extracellular matrix invasion) |
22784357 |
View |
fascin |
Fascin actin-bundling protein 1 |
Fascin |
prognosis(different steps of extracellular matrix invasion) |
22784357 |
View |
fascin |
Fascin actin-bundling protein 1 |
Fascin |
prognosis(different steps of extracellular matrix invasion) |
22784357 |
View |
CD44v6 |
N/A |
N/A |
prognosis |
22784357 |
View |
IDO |
indoleamine 2,3-dioxygenase 1;indoleamine 2,3-dioxygenase 2; |
N/A |
diagnosis |
33660848 |
View |
BST2 |
bone marrow stromal cell antigen 2 |
Bone marrow stromal antigen 2 |
treatment(therapeutic target) |
22729361 |
View |
IPO13 |
Importin 13 |
Importin-13 |
diagnosis |
22648251 |
View |
pHH3 |
N/A |
N/A |
prognosis(unfavorable) |
22644303 |
View |
survivin |
Baculoviral IAP repeat containing 5 |
Baculoviral IAP repeat-containing protein 5 |
prognosis(unfavorable) |
22644303 |
View |
emmprin |
basigin (Ok blood group) |
Basigin |
prognosis(favorable) |
22640183 |
View |
emmprin |
basigin (Ok blood group) |
Basigin |
treatment(therapeutic target) |
22640183 |
View |
bFGF |
fibroblast growth factor 2 |
Fibroblast growth factor 2 |
prognosis |
22617129 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
prognosis(unfavorable) |
22525819 |
View |
podocalyxin |
podocalyxin like |
Podocalyxin |
diagnosis(aggressive phenotype) |
22412054 |
View |
pEzrin |
Ezrin |
Ezrin |
diagnosis(aggressive phenotype) |
22412054 |
View |
SMA |
Actin gamma 2, smooth muscle |
Actin, gamma-enteric smooth muscle |
diagnosis |
34556086 |
View |
BMP-10 |
Bone morphogenetic protein 10 |
Bone morphogenetic protein 10 |
prognosis(unfavorable) |
33635467 |
View |
Notch-1 |
Notch receptor 1 |
Neurogenic locus notch homolog protein 1 |
diagnosis |
22378079 |
View |
GGT |
gamma-glutamyltransferase 1 |
Glutathione hydrolase 1 proenzyme |
prognosis(unfavorable) |
22315051 |
View |
TIMP-2 |
TIMP metallopeptidase inhibitor 2 |
Metalloproteinase inhibitor 2 |
prognosis(favorable) |
22270451 |
View |
HMGA2 |
High mobility group AT-hook 2 |
High mobility group protein HMGI-C |
diagnosis |
22250726 |
View |
phosphatidylinositol 3'-kinase pathway alteration |
N/A |
N/A |
prognosis(favorable) |
22209294 |
View |
SPAG9 |
sperm associated antigen 9 |
C-Jun-amino-terminal kinase-interacting protein 4 |
diagnosis(early detection of endometrial carcinoma) |
22146769 |
View |
endoglin |
Endoglin |
Endoglin |
prognosis |
22116456 |
View |
MMP-2 |
matrix metallopeptidase 2 |
72 kDa type IV collagenase |
diagnosis(different stages of endometriosis and in endometrial cancer) |
22056701 |
View |
MMP-9 |
Matrix metallopeptidase 9 |
Matrix metalloproteinase-9 |
diagnosis(different stages of endometriosis and in endometrial cancer) |
22056701 |
View |
PCNA |
Proliferating cell nuclear antigen |
Proliferating cell nuclear antigen |
diagnosis(different stages of endometriosis and in endometrial cancer) |
22056701 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis(low risk) |
33528032 |
View |
CA-125 |
Mucin 16, cell surface associated |
N/A |
diagnosis |
22037740 |
View |
CA-125 |
Mucin 16, cell surface associated |
N/A |
diagnosis |
22037740 |
View |
CA-125 |
Mucin 16, cell surface associated |
N/A |
diagnosis |
22037740 |
View |
CA-125 |
Mucin 16, cell surface associated |
N/A |
diagnosis |
22037740 |
View |
CA-125 |
Mucin 16, cell surface associated |
N/A |
diagnosis |
22037740 |
View |
CA-125 |
Mucin 16, cell surface associated |
N/A |
diagnosis |
22037740 |
View |
CA-125 |
Mucin 16, cell surface associated |
N/A |
diagnosis |
22037740 |
View |
CA-125 |
Mucin 16, cell surface associated |
N/A |
diagnosis |
22037740 |
View |
p16 |
Cyclin dependent kinase inhibitor 2A |
Tumor suppressor ARF |
diagnosis |
22027748 |
View |
CXCL12 |
C-X-C motif chemokine ligand 12 |
Stromal cell-derived factor 1 |
prognosis(favorable) |
22025313 |
View |
SATB2 |
SATB2 (FLJ21474, KIAA1034) |
DNA-binding protein SATB2 |
diagnosis(Separating atypical endometrioid glands is more consistent with
APAM than with myoinvasive) |
33459390 |
View |
SNCG |
Synuclein gamma |
Gamma-synuclein |
diagnosis(aggressive tumor behavior and adverse outcome) |
22015044 |
View |
hPRL |
prolactin |
Prolactin |
prognosis(unfavorable) |
21849525 |
View |
hGH |
growth hormone 1 |
Somatotropin |
prognosis(unfavorable) |
21849525 |
View |
CA 125 |
Mucin 16, cell surface associated |
N/A |
prognosis(unfavorable) |
21846440 |
View |
CA 125 |
Mucin 16, cell surface associated |
N/A |
prognosis(unfavorable) |
21806586 |
View |
Beclin 1 |
beclin 1 |
Beclin-1 |
prognosis(unfavorable) |
21741077 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis(predict myometrial invasion) |
21720250 |
View |
GDF-15 |
growth differentiation factor 15 |
Growth/differentiation factor 15 |
prognosis(unfavorable) |
21616994 |
View |
GDF-15 |
growth differentiation factor 15 |
Growth/differentiation factor 15 |
treatment(monitoring treatment) |
21616994 |
View |
GDF-15 |
growth differentiation factor 15 |
Growth/differentiation factor 15 |
prognosis(unfavorable) |
21616994 |
View |
p16 |
Cyclin dependent kinase inhibitor 2A |
Tumor suppressor ARF |
diagnosis(Separating atypical endometrioid glands is more consistent with
APAM than with myoinvasive) |
33459390 |
View |
Ki-67 nuclear antigen labeling |
marker of proliferation Ki-67 |
Proliferation marker protein Ki-67 |
treatment |
21551965 |
View |
CD151 |
CD151 molecule (Raph blood group) |
CD151 antigen |
prognosis(unfavorable) |
21505452 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
prognosis(unfavorable) |
21468050 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
prognosis(unfavorable) |
21468050 |
View |
Stathmin |
Stathmin 1 |
Stathmin |
prognosis(unfavorable) |
21242118 |
View |
Stathmin |
Stathmin 1 |
Stathmin |
treatment(predictive marker for response to PI3Kinase inhibition ) |
21242118 |
View |
ALDH1 |
aldehyde dehydrogenase 1 family member A1 |
Aldehyde dehydrogenase 1A1 |
prognosis(unfavorable) |
21231983 |
View |
Nrf2 |
N/A |
N/A |
diagnosis |
21228930 |
View |
PTTG1 |
PTTG1 regulator of sister chromatid separation, securin |
Securin |
prognosis |
21181309 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
prognosis |
21181309 |
View |
MMR protein |
N/A |
N/A |
treatment(response to adjuvant therapy) |
33449452 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
prognosis |
21181309 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
prognosis |
21181309 |
View |
inhibin-α subunit |
inhibin subunit alpha |
Inhibin alpha chain |
prognosis(unfavorable) |
21174065 |
View |
VEGF |
vascular endothelial growth factor A |
Vascular endothelial growth factor A |
prognosis(unfavorable) |
21103625 |
View |
VEGF |
vascular endothelial growth factor A |
Vascular endothelial growth factor A |
prognosis(unfavorable) |
21103625 |
View |
E-cadherin |
cadherin 1 |
Cadherin-1 |
prognosis |
20874004 |
View |
E-cadherin |
cadherin 1 |
Cadherin-1 |
treatment(therapeutic target) |
20874004 |
View |
HAI-1 |
serine peptidase inhibitor, Kunitz type 1 |
Kunitz-type protease inhibitor 1 |
prognosis(favorable) |
20715109 |
View |
HAI-2 |
Serine peptidase inhibitor, Kunitz type 2 |
Kunitz-type protease inhibitor 2 |
prognosis(favorable) |
20715109 |
View |
HAI-1 |
serine peptidase inhibitor, Kunitz type 1 |
Kunitz-type protease inhibitor 1 |
treatment(therapeutic target) |
20715109 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis |
33436780 |
View |
HAI-2 |
Serine peptidase inhibitor, Kunitz type 2 |
Kunitz-type protease inhibitor 2 |
treatment(therapeutic target) |
20715109 |
View |
YT521 |
YTH domain containing 1 |
YTH domain-containing protein 1 |
prognosis(unfavorable) |
20686370 |
View |
YT521 |
YTH domain containing 1 |
YTH domain-containing protein 1 |
prognosis(unfavorable) |
20686370 |
View |
HIF-1alpha |
Hypoxia inducible factor 1 subunit alpha |
Hypoxia-inducible factor 1-alpha |
prognosis(unfavorable) |
20565904 |
View |
Glut-1 |
solute carrier family 2 member 1 |
Solute carrier family 2, facilitated glucose transporter member 1 |
diagnosis(endometrial intraepithelial neoplasia) |
20527231 |
View |
Glut-1 |
solute carrier family 2 member 1 |
Solute carrier family 2, facilitated glucose transporter member 1 |
diagnosis(endometrial intraepithelial neoplasia) |
20527231 |
View |
beta-catenin |
Catenin beta 1 |
Catenin beta-1 |
diagnosis(endometrial intraepithelial neoplasia) |
20527231 |
View |
beta-catenin |
Catenin beta 1 |
Catenin beta-1 |
diagnosis(endometrial intraepithelial neoplasia) |
20527231 |
View |
beta-catenin |
Catenin beta 1 |
Catenin beta-1 |
diagnosis(endometrial intraepithelial neoplasia) |
20527231 |
View |
L1CAM |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
diagnosis(identify endometrioid ECs that have type 2-like features) |
20077528 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis |
33388311 |
View |
myocardin |
myocardin |
Myocardin |
diagnosis(distinguishing uterine smooth muscle tumors from ESSs) |
19952936 |
View |
myocardin |
myocardin |
Myocardin |
diagnosis(distinguishing uterine smooth muscle tumors from ESSs) |
19952936 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
19855378 |
View |
FAK |
protein tyrosine kinase 2 |
Focal adhesion kinase 1 |
prognosis(unfavorable) |
19823058 |
View |
Claudins |
N/A |
N/A |
diagnosis |
19795358 |
View |
Claudins |
N/A |
N/A |
prognosis |
19795358 |
View |
Claudins |
N/A |
N/A |
treatment |
19795358 |
View |
RFP |
N/A |
N/A |
prognosis(unfavorable) |
19650860 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
19509570 |
View |
DKK1 |
Dickkopf WNT signaling pathway inhibitor 1 |
Dickkopf-related protein 1 |
diagnosis(screening the progression) |
19424619 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis |
33388311 |
View |
DKK1 |
Dickkopf WNT signaling pathway inhibitor 1 |
Dickkopf-related protein 1 |
diagnosis(screening the progression) |
19424619 |
View |
EphA2 |
EPH receptor A2 |
Ephrin type-A receptor 2 |
treatment(hormone receptor-negative) |
19396818 |
View |
EphA2 |
EPH receptor A2 |
Ephrin type-A receptor 2 |
treatment(hormone receptor-negative) |
19396818 |
View |
osteopontin |
secreted phosphoprotein 1 |
Osteopontin |
prognosis(unfavorable) |
19194826 |
View |
osteopontin |
secreted phosphoprotein 1 |
Osteopontin |
prognosis(unfavorable) |
19194826 |
View |
Ki-67 |
marker of proliferation Ki-67 |
Proliferation marker protein Ki-67 |
prognosis(unfavorable) |
19133508 |
View |
ER |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
prognosis(unfavorable) |
19133508 |
View |
PR |
Progesterone receptor |
Progesterone receptor |
prognosis(unfavorable) |
19133508 |
View |
Cathepsin-B |
cathepsin B |
Cathepsin B |
prognosis(unfavorable) |
19110306 |
View |
progesterone receptor (PR)-A |
Progesterone receptor |
Progesterone receptor |
prognosis(favorable) |
19108875 |
View |
CA125 |
Mucin 16, cell surface associated |
N/A |
diagnosis |
33388311 |
View |
ER-alpha |
estrogen receptor 1 |
Estrogen receptor |
prognosis(favorable) |
19108875 |
View |
SOD |
N/A |
N/A |
treatment(therapeutic target) |
18797802 |
View |
SOD |
N/A |
N/A |
treatment(therapeutic target) |
18797802 |
View |
TFF3 |
trefoil factor 3 |
Trefoil factor 3 |
diagnosis |
18682706 |
View |
TFF3 |
trefoil factor 3 |
Trefoil factor 3 |
diagnosis |
18682706 |
View |
CD10 |
membrane metalloendopeptidase |
Neprilysin |
diagnosis |
18565690 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis |
18495222 |
View |
BMI-1 |
BMI1 proto-oncogene, polycomb ring finger |
Polycomb complex protein BMI-1 |
prognosis(unfavorable) |
18475299 |
View |
ADAM19 |
ADAM metallopeptidase domain 19 |
Disintegrin and metalloproteinase domain-containing protein 19 |
prognosis(the progress and prognosis of endometrial carcinoma) |
18458692 |
View |
ADAM19 |
ADAM metallopeptidase domain 19 |
Disintegrin and metalloproteinase domain-containing protein 19 |
prognosis(the progress and prognosis of endometrial carcinoma) |
18458692 |
View |
estrogen receptor |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
prognosis |
33338506 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
diagnosis |
18431720 |
View |
beta-catenin |
Catenin beta 1 |
Catenin beta-1 |
diagnosis(aid in the stratification of EC into low grade and high grade EC) |
18431720 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
diagnosis(high-grade EC in endometrial cytology) |
18431720 |
View |
Midkine (MK) |
midkine |
Midkine |
prognosis(unfavorable) |
18422745 |
View |
Midkine (MK) |
midkine |
Midkine |
prognosis(unfavorable) |
18422745 |
View |
NDRG1 |
N-myc downstream regulated 1 |
Protein NDRG1 |
diagnosis(early detection of endometrial carcinoma) |
18377423 |
View |
NDRG1 |
N-myc downstream regulated 1 |
Protein NDRG1 |
diagnosis(early detection of endometrial carcinoma) |
18377423 |
View |
NDRG1 |
N-myc downstream regulated 1 |
Protein NDRG1 |
diagnosis(early detection of endometrial carcinoma) |
18377423 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
diagnosis(early detection of endometrial carcinoma) |
18377423 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
diagnosis(early detection of endometrial carcinoma) |
18377423 |
View |
SMA |
Actin alpha 2, smooth muscle |
Actin, aortic smooth muscle |
diagnosis |
34556086 |
View |
progesterone receptor |
Progesterone receptor |
Progesterone receptor |
prognosis |
33338506 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
diagnosis(early detection of endometrial carcinoma) |
18377423 |
View |
beta-catenin |
Catenin beta 1 |
Catenin beta-1 |
diagnosis |
18376386 |
View |
Prostate-specific membrane antigen |
Folate hydrolase 1 |
N/A |
prognosis(unfavorable) |
18349274 |
View |
aquaporin-1 (AQP1) |
aquaporin 1 |
Aquaporin-1 |
treatment(therapeutic target) |
18313673 |
View |
TAMs |
N/A |
N/A |
prognosis(unfavorable) |
18289648 |
View |
IMP3 |
IMP U3 small nucleolar ribonucleoprotein 3 |
U3 small nucleolar ribonucleoprotein protein IMP3 |
diagnosis |
18223334 |
View |
IMP3 |
IMP U3 small nucleolar ribonucleoprotein 3 |
U3 small nucleolar ribonucleoprotein protein IMP3 |
diagnosis |
18223334 |
View |
IMP3 |
IMP U3 small nucleolar ribonucleoprotein 3 |
U3 small nucleolar ribonucleoprotein protein IMP3 |
diagnosis |
18223334 |
View |
IMP3 |
IMP U3 small nucleolar ribonucleoprotein 3 |
U3 small nucleolar ribonucleoprotein protein IMP3 |
diagnosis |
18223334 |
View |
IMP3 |
IMP U3 small nucleolar ribonucleoprotein 3 |
U3 small nucleolar ribonucleoprotein protein IMP3 |
diagnosis(endometrial stroma of gestational endometrium and chorionic villi) |
18223334 |
View |
folate receptor alpha |
Folate receptor alpha |
Folate receptor alpha |
treatment(therapeutic target) |
33323854 |
View |
CRP |
C-reactive protein |
C-reactive protein |
prognosis(unfavorable) |
18055714 |
View |
p53 antibody (S-p53 Ab) |
tumor protein p53 |
Cellular tumor antigen p53 |
diagnosis |
17980190 |
View |
p53 antibody (S-p53 Ab) |
tumor protein p53 |
Cellular tumor antigen p53 |
diagnosis |
17980190 |
View |
c-erb-B2 |
Erb-b2 receptor tyrosine kinase 2 |
Receptor tyrosine-protein kinase erbB-2 |
prognosis(unfavorable) |
17890888 |
View |
c-erb-B2 |
Erb-b2 receptor tyrosine kinase 2 |
Receptor tyrosine-protein kinase erbB-2 |
prognosis(unfavorable) |
17890888 |
View |
c-erb-B2 |
Erb-b2 receptor tyrosine kinase 2 |
Receptor tyrosine-protein kinase erbB-2 |
prognosis(unfavorable) |
17890888 |
View |
IMP3 |
IMP U3 small nucleolar ribonucleoprotein 3 |
U3 small nucleolar ribonucleoprotein protein IMP3 |
diagnosis |
17885673 |
View |
IMP3 |
IMP U3 small nucleolar ribonucleoprotein 3 |
U3 small nucleolar ribonucleoprotein protein IMP3 |
diagnosis |
17885673 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
diagnosis |
17885673 |
View |
HLDF factor |
N/A |
N/A |
diagnosis |
17722590 |
View |
folate receptor alpha |
Folate receptor alpha |
Folate receptor alpha |
treatment(therapeutic target) |
33323854 |
View |
FOLR1 |
folate receptor alpha |
Folate receptor alpha |
prognosis(unfavorable) |
17582475 |
View |
BNIP3 |
BCL2 interacting protein 3 |
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 |
prognosis(unfavorable) |
17513511 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
prognosis(unfavorable) |
17504383 |
View |
beta-catenin |
Catenin beta 1 |
Catenin beta-1 |
prognosis(unfavorable) |
17504383 |
View |
GPR30 |
G protein-coupled estrogen receptor 1 |
G-protein coupled estrogen receptor 1 |
prognosis(unfavorable) |
17403429 |
View |
CA-125 |
Mucin 16, cell surface associated |
N/A |
diagnosis(lymph node metastasis (LNM)) |
17260229 |
View |
CD24 |
CD24 molecule |
Signal transducer CD24 |
prognosis(unfavorable) |
17139987 |
View |
oestrogen receptor |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
prognosis(unfavorable) |
17130035 |
View |
Ki-67 |
marker of proliferation Ki-67 |
Proliferation marker protein Ki-67 |
prognosis |
17130035 |
View |
Indoleamine 2,3-dioxygenase |
indoleamine 2,3-dioxygenase 1 |
N/A |
prognosis |
17117179 |
View |
folate receptor alpha |
Folate receptor alpha |
Folate receptor alpha |
treatment(therapeutic target) |
33323854 |
View |
ephrinB2 |
Ephrin B2 |
Ephrin-B2 |
prognosis(unfavorable) |
17108150 |
View |
EphB4 |
EPH receptor B4 |
Ephrin type-B receptor 4 |
prognosis(unfavorable) |
17108150 |
View |
HIF-1alpha |
Hypoxia inducible factor 1 subunit alpha |
Hypoxia-inducible factor 1-alpha |
diagnosis(aggressive potentia in type I) |
17099695 |
View |
ERalpha |
estrogen receptor 1 |
Estrogen receptor |
prognosis(favorable) |
17068614 |
View |
ERRalpha |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
prognosis(unfavorable) |
17068614 |
View |
ERalpha |
estrogen receptor 1 |
Estrogen receptor |
prognosis |
17068614 |
View |
ERRalpha |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
prognosis |
17068614 |
View |
versican |
Versican |
Versican core protein |
prognosis(unfavorable) |
17065588 |
View |
versican |
Versican |
Versican core protein |
prognosis(unfavorable) |
17065588 |
View |
versican |
Versican |
Versican core protein |
prognosis(unfavorable) |
17065588 |
View |
P53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
33237570 |
View |
versican |
Versican |
Versican core protein |
prognosis(unfavorable) |
17065588 |
View |
YKL-40 |
Chitinase 3 like 1 |
N/A |
prognosis(unfavorable) |
17023034 |
View |
PRA |
Progesterone receptor |
Progesterone receptor |
prognosis(risk factor in disease-free survival of the patients) |
16999816 |
View |
PRB |
Progesterone receptor |
Progesterone receptor |
prognosis(risk factor in disease-free survival of the patients) |
16999816 |
View |
AIB1 |
nuclear receptor coactivator 3 |
Nuclear receptor coactivator 3 |
prognosis(unfavorable) |
16980945 |
View |
AIB1 |
nuclear receptor coactivator 3 |
Nuclear receptor coactivator 3 |
prognosis(unfavorable) |
16980945 |
View |
Nm23 |
NME/NM23 nucleoside diphosphate kinase 1 |
Nucleoside diphosphate kinase A |
prognosis(favorable) |
16919631 |
View |
Nm23 |
NME/NM23 nucleoside diphosphate kinase 1 |
Nucleoside diphosphate kinase A |
prognosis(favorable) |
16919631 |
View |
GLUT1 |
solute carrier family 2 member 1 |
Solute carrier family 2, facilitated glucose transporter member 1 |
diagnosis |
16892013 |
View |
GLUT8 |
solute carrier family 2 member 8 |
Solute carrier family 2, facilitated glucose transporter member 8 |
diagnosis |
16892013 |
View |
P53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
33237570 |
View |
KLK8 |
Kallikrein related peptidase 8 |
Kallikrein-8 |
diagnosis |
16888409 |
View |
CD105 |
Endoglin |
Endoglin |
prognosis(favorable) |
16854456 |
View |
CD105 |
Endoglin |
Endoglin |
prognosis(favorable) |
16854456 |
View |
RCAS1 |
Estrogen receptor binding site associated antigen 9 |
Receptor-binding cancer antigen expressed on SiSo cells |
treatment(WST-1 assay,inhibit
growth of immune cells) |
16842844 |
View |
LDH-5 |
N/A |
N/A |
prognosis(unfavorable) |
16837029 |
View |
Lactoferrin (Lf) |
lactotransferrin |
Lactotransferrin |
prognosis(unfavorable) |
16820900 |
View |
E-cadherin |
cadherin 1 |
Cadherin-1 |
prognosis(favorable) |
16803534 |
View |
alpha-catenin |
N/A |
N/A |
prognosis(favorable) |
16803534 |
View |
beta-catenin |
Catenin beta 1 |
Catenin beta-1 |
prognosis(favorable) |
16803534 |
View |
HER-2 |
erb-b2 receptor tyrosine kinase 2 |
N/A |
prognosis(unfavorable) |
16710036 |
View |
P53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
33237570 |
View |
HER-2 |
erb-b2 receptor tyrosine kinase 2 |
N/A |
prognosis(unfavorable) |
16710036 |
View |
CRBP-1 |
Retinol binding protein 1 |
Retinol-binding protein 1 |
diagnosis(additional useful tool for grading of endometrial carcinoma and may help to detect areas of differentiation) |
16575402 |
View |
CRBP-1 |
Retinol binding protein 1 |
Retinol-binding protein 1 |
treatment(potential therapeutic target for pharmacological strategies aimed to counteract its progression by increased intracellular retinol bioavailability) |
16575402 |
View |
Twist |
twist family bHLH transcription factor 1 |
Twist-related protein 1 |
prognosis(unfavorable) |
16564917 |
View |
Twist |
twist family bHLH transcription factor 1 |
Twist-related protein 1 |
treatment(therapeutic target) |
16564917 |
View |
HDAC8 |
histone deacetylase 8 |
Histone deacetylase 8 |
diagnosis(smooth muscle differentiation) |
16538051 |
View |
HDAC8 |
histone deacetylase 8 |
Histone deacetylase 8 |
diagnosis(smooth muscle differentiation) |
16538051 |
View |
HDAC8 |
histone deacetylase 8 |
Histone deacetylase 8 |
diagnosis(smooth muscle differentiation) |
16538051 |
View |
HDAC8 |
histone deacetylase 8 |
Histone deacetylase 8 |
diagnosis(smooth muscle differentiation) |
16538051 |
View |
p27 |
Cyclin dependent kinase inhibitor 1B |
Cyclin-dependent kinase inhibitor 1B |
treatment(predicting marker for medroxyprogesterone acetate therapy) |
16515645 |
View |
TWIST1 |
twist family bHLH transcription factor 1 |
Twist-related protein 1 |
diagnosis(diagnosis AHs and type I ECs) |
33235117 |
View |
cyclin H |
Cyclin H |
Cyclin-H |
prognosis(unfavorable) |
16445666 |
View |
cyclin H |
Cyclin H |
Cyclin-H |
prognosis(unfavorable) |
16445666 |
View |
Aurora B |
Aurora kinase B |
Aurora kinase B |
prognosis(unfavorable) |
16311121 |
View |
14-3-3sigma |
Stratifin |
14-3-3 protein sigma |
prognosis(unfavorable) |
16243811 |
View |
skp2 |
S-phase kinase associated protein 2 |
S-phase kinase-associated protein 2 |
prognosis(unfavorable) |
16080017 |
View |
S100 |
N/A |
N/A |
prognosis(favorable) |
16033094 |
View |
beta-catenin (CTNNB1) |
Catenin beta 1 |
Catenin beta-1 |
prognosis(favorable) |
16021566 |
View |
c-FLIP |
CASP8 and FADD like apoptosis regulator |
CASP8 and FADD-like apoptosis regulator |
prognosis(unfavorable) |
16014121 |
View |
CD10 |
membrane metalloendopeptidase |
Neprilysin |
diagnosis |
15938828 |
View |
SMA |
Actin gamma 2, smooth muscle |
Actin, gamma-enteric smooth muscle |
diagnosis |
15938828 |
View |
LGALS3BP |
Galectin 3 binding protein |
Galectin-3-binding protein |
diagnosis |
33208911 |
View |
HER-2 |
erb-b2 receptor tyrosine kinase 2 |
N/A |
prognosis(unfavorable) |
15938112 |
View |
Ki-67 |
marker of proliferation Ki-67 |
Proliferation marker protein Ki-67 |
prognosis(unfavorable) |
15938112 |
View |
Human kallikrein 6 (hK6) |
Kallikrein related peptidase 6 |
Kallikrein-6 |
prognosis(early disease recurrence and response to therapy) |
15867230 |
View |
Human kallikrein 6 (hK6) |
Kallikrein related peptidase 6 |
Kallikrein-6 |
prognosis(early disease recurrence and response to therapy) |
15867230 |
View |
ATP7B |
ATPase copper transporting beta |
Copper-transporting ATPase 2 |
prognosis(unfavorable,in patients treated with cisplatin-based chemotherapy) |
15790435 |
View |
MCM7 |
minichromosome maintenance complex component 7 |
DNA replication licensing factor MCM7 |
prognosis(unfavorable) |
15720416 |
View |
c-erbB2 |
Erb-b2 receptor tyrosine kinase 2 |
Receptor tyrosine-protein kinase erbB-2 |
prognosis(unfavorable) |
15678850 |
View |
cytokeratin |
N/A |
N/A |
diagnosis(predict lymph node micrometastasis) |
15498190 |
View |
cytokeratin |
N/A |
N/A |
diagnosis(predict lymph node micrometastasis) |
15498190 |
View |
cytokeratin |
N/A |
N/A |
diagnosis(predict lymph node micrometastasis) |
15498190 |
View |
LGALS3BP |
Galectin 3 binding protein |
Galectin-3-binding protein |
prognosis(unfavorable) |
33208911 |
View |
CA125 |
Mucin 16, cell surface associated |
N/A |
diagnosis(predict lymph node micrometastasis) |
15498190 |
View |
CA125 |
Mucin 16, cell surface associated |
N/A |
diagnosis(predict lymph node micrometastasis) |
15498190 |
View |
CA125 |
Mucin 16, cell surface associated |
N/A |
diagnosis(predict lymph node micrometastasis) |
15498190 |
View |
P53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
15363194 |
View |
C-erbB-2 |
Erb-b2 receptor tyrosine kinase 2 |
Receptor tyrosine-protein kinase erbB-2 |
prognosis(unfavorable) |
15363194 |
View |
E-cadherin |
cadherin 1 |
Cadherin-1 |
prognosis(favorable) |
15328195 |
View |
chaperonin 10 |
N/A |
N/A |
diagnosis |
15253447 |
View |
CD171 |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
prognosis(favorable) |
15225093 |
View |
CD171 |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
diagnosis(detected subclinical
disease reconfirmed by the second-look surgery) |
15225093 |
View |
placental leucine aminopeptidase |
leucyl and cystinyl aminopeptidase |
Leucyl-cystinyl aminopeptidase |
prognosis(unfavorable) |
15218296 |
View |
h-caldesmon |
Caldesmon 1 |
Caldesmon |
diagnosis |
34556086 |
View |
LGALS3BP |
Galectin 3 binding protein |
Galectin-3-binding protein |
diagnosis |
33208911 |
View |
vascular invasion |
N/A |
N/A |
prognosis(unfavorable) |
15139995 |
View |
vascular invasion |
N/A |
N/A |
prognosis(unfavorable) |
15139995 |
View |
tumour cell proliferation (Ki67) |
marker of proliferation Ki-67 |
Proliferation marker protein Ki-67 |
prognosis(unfavorable) |
15139995 |
View |
p53 index |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
15084841 |
View |
P-cadherin |
Cadherin 3 |
Cadherin-3 |
prognosis(unfavorable) |
15051772 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
diagnosis(predicting aggressive behavior) |
15032075 |
View |
cFLIP |
CASP8 and FADD like apoptosis regulator |
CASP8 and FADD-like apoptosis regulator |
prognosis |
15025952 |
View |
telomerase |
N/A |
N/A |
prognosis(unfavorable) |
15025282 |
View |
uPA |
N/A |
N/A |
prognosis(unfavorable) |
14976916 |
View |
c-myc |
MYC proto-oncogene, bHLH transcription factor |
Myc proto-oncogene protein |
prognosis(unfavorable) |
14764041 |
View |
LGALS3BP |
Galectin 3 binding protein |
Galectin-3-binding protein |
prognosis(unfavorable) |
33208911 |
View |
fatty acid synthase (FAS) |
Fatty acid synthase |
Fatty acid synthase |
prognosis(increased risk of recurrence) |
14751145 |
View |
CD105 |
Endoglin |
Endoglin |
prognosis(unfavorable) |
14629267 |
View |
oxytocin receptor |
Oxytocin receptor |
Oxytocin receptor |
diagnosis(distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma) |
14576480 |
View |
oxytocin receptor |
Oxytocin receptor |
Oxytocin receptor |
diagnosis(distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma) |
14576480 |
View |
oxytocin receptor |
Oxytocin receptor |
Oxytocin receptor |
diagnosis(distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma) |
14576480 |
View |
oxytocin receptor |
Oxytocin receptor |
Oxytocin receptor |
diagnosis(distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma) |
14576480 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
diagnosis(earliest endometrial precancers and adenocarcinoma) |
12948417 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
diagnosis(earliest endometrial precancers and adenocarcinoma) |
12948417 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
diagnosis(earliest endometrial precancers and adenocarcinoma) |
12948417 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
diagnosis(earliest endometrial precancers and adenocarcinoma) |
12948417 |
View |
PPARγ(-) |
Peroxisome proliferator activated receptor gamma |
Peroxisome proliferator-activated receptor gamma |
prognosis(unfavorable) |
33197888 |
View |
CA 125 |
Mucin 16, cell surface associated |
N/A |
prognosis |
12926169 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
12895227 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
12895227 |
View |
MIB1 |
MIB E3 ubiquitin protein ligase 1 |
E3 ubiquitin-protein ligase MIB1 |
prognosis(unfavorable) |
12893199 |
View |
HER-2 |
erb-b2 receptor tyrosine kinase 2 |
N/A |
prognosis(unfavorable) |
12866577 |
View |
IGF-IR |
insulin like growth factor 1 receptor |
Insulin-like growth factor 1 receptor |
prognosis(unfavorable) |
12866376 |
View |
CEA |
N/A |
Carcinoembryonic antigen-related cell adhesion molecule |
prognosis(unfavorable) |
12820355 |
View |
CA-125 |
Mucin 16, cell surface associated |
N/A |
prognosis(marker of malignant cell transformation) |
12820350 |
View |
endoglin (CD105) |
Endoglin |
Endoglin |
prognosis(positive correlation with angiolymphatic invasion, lymph node metastases, and tumor stage) |
12819391 |
View |
Elf-1 |
E74 like ETS transcription factor 1 |
ETS-related transcription factor Elf-1 |
prognosis(unfavorable) |
12798703 |
View |
ERRα(+) |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
prognosis(unfavorable) |
33197888 |
View |
cyclin A |
cyclin A1 |
Cyclin-A1 |
prognosis(unfavorable) |
12792921 |
View |
17beta-HSD type 2 |
cyclin A2 |
Cyclin-A2 |
treatment(progestogen treatment) |
12780745 |
View |
17beta-HSD type 2 |
cyclin A2 |
Cyclin-A2 |
treatment(progestogen treatment) |
12780745 |
View |
17beta-HSD type 2 |
cyclin A2 |
Cyclin-A2 |
treatment(progestogen treatment) |
12780745 |
View |
PRB |
Progesterone receptor |
Progesterone receptor |
treatment(progestogen treatment) |
12780745 |
View |
CD44 variant 6 |
CD44 molecule (Indian blood group) |
CD44 antigen |
prognosis |
12747468 |
View |
beta-catenin |
Catenin beta 1 |
Catenin beta-1 |
treatment(progestogen treatment) |
12708483 |
View |
Ki-S1 |
DNA topoisomerase II alpha |
DNA topoisomerase 2-alpha |
diagnosis(classifying patients into subgroups with low and high risk of relapseA) |
12556100 |
View |
CaMKIV |
calcium/calmodulin dependent protein kinase IV |
Calcium/calmodulin-dependent protein kinase type IV |
prognosis(unfavorable) |
12525874 |
View |
h-caldesmon |
Caldesmon 1 |
Caldesmon |
diagnosis |
12485478 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis(predicte advanced disease ) |
33156532 |
View |
h-caldesmon |
Caldesmon 1 |
Caldesmon |
diagnosis |
12485478 |
View |
calponin |
calponin 1 |
Calponin-1 |
diagnosis |
12485478 |
View |
calponin |
calponin 1 |
Calponin-1 |
diagnosis |
12485478 |
View |
CD10 |
membrane metalloendopeptidase |
Neprilysin |
diagnosis |
12485478 |
View |
CD10 |
membrane metalloendopeptidase |
Neprilysin |
diagnosis |
12485478 |
View |
Desmin |
Desmin |
Desmin |
diagnosis |
12485478 |
View |
Desmin |
Desmin |
Desmin |
diagnosis |
12485478 |
View |
SMA |
Actin gamma 2, smooth muscle |
Actin, gamma-enteric smooth muscle |
diagnosis |
12485478 |
View |
SMA |
Actin gamma 2, smooth muscle |
Actin, gamma-enteric smooth muscle |
diagnosis |
12485478 |
View |
VEGF |
vascular endothelial growth factor A |
Vascular endothelial growth factor A |
diagnosis(monitoring the progress of the disease) |
12479072 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis(predicte advanced disease ) |
33156532 |
View |
UPAR |
Plasminogen activator, urokinase receptor |
Urokinase plasminogen activator surface receptor |
prognosis(unfavorable) |
12130664 |
View |
Cyclin A |
cyclin A2 |
Cyclin-A2 |
prognosis(unfavorable) |
12073048 |
View |
CA125 |
Mucin 16, cell surface associated |
N/A |
prognosis(unfavorable) |
11930622 |
View |
AgNORs |
N/A |
N/A |
treatment(predict, as early as after the first fraction, the
local control of disease by a full radiotherapy protocol) |
11917578 |
View |
MUC1 |
Mucin 1, cell surface associated |
Mucin-1 |
prognosis(favorable) |
11903603 |
View |
MUC1 |
Mucin 1, cell surface associated |
Mucin-1 |
prognosis(favorable) |
11903603 |
View |
VEGF |
vascular endothelial growth factor A |
Vascular endothelial growth factor A |
prognosis(favorable) |
11745191 |
View |
KDR |
kinase insert domain receptor |
Vascular endothelial growth factor receptor 2 |
prognosis(favorable) |
11745191 |
View |
VEGF |
vascular endothelial growth factor A |
Vascular endothelial growth factor A |
prognosis(unfavorable) |
11745191 |
View |
CD10 |
membrane metalloendopeptidase |
Neprilysin |
diagnosis |
11532038 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
prognosis(unfavorable) |
33148127 |
View |
CD10 |
membrane metalloendopeptidase |
Neprilysin |
diagnosis |
11532038 |
View |
EMA |
N/A |
N/A |
prognosis(unfavorable) |
11520144 |
View |
EMA |
N/A |
N/A |
prognosis(unfavorable) |
11520144 |
View |
EMA |
N/A |
N/A |
prognosis(unfavorable) |
11520144 |
View |
Nuclear p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
11516808 |
View |
endostatin |
Collagen type XVIII alpha 1 chain |
Collagen alpha-1(XVIII) chain |
treatment(decreased significantly after treatment,marked elevations at clinical relapse) |
11504312 |
View |
VEGF |
vascular endothelial growth factor A |
Vascular endothelial growth factor A |
treatment(decreased significantly after treatment,marked elevations at clinical relapse) |
11504312 |
View |
telomerase |
N/A |
N/A |
prognosis(unfavorable) |
11431715 |
View |
Id1 |
Inhibitor of DNA binding 1, HLH protein |
DNA-binding protein inhibitor ID-1 |
diagnosis(malignant potential) |
11275368 |
View |
CA125 |
Mucin 16, cell surface associated |
N/A |
prognosis(unfavorable) |
11268474 |
View |
FTO |
FTO alpha-ketoglutarate dependent dioxygenase |
Alpha-ketoglutarate-dependent dioxygenase FTO |
treatment(therapeutic target) |
33103587 |
View |
VEGF |
vascular endothelial growth factor A |
Vascular endothelial growth factor A |
prognosis(unfavorable) |
11161861 |
View |
cytokeratin |
N/A |
N/A |
prognosis(risk factor for recurrence) |
11161851 |
View |
cytokeratin |
N/A |
N/A |
prognosis(risk factor for recurrence) |
11161851 |
View |
cytokeratin |
N/A |
N/A |
prognosis(risk factor for recurrence) |
11161851 |
View |
PAI-1 |
serpin family E member 1 |
Plasminogen activator inhibitor 1 |
prognosis(unfavorable) |
11136569 |
View |
telomerase activity |
N/A |
N/A |
diagnosis |
11078809 |
View |
telomerase activity |
N/A |
N/A |
diagnosis |
11078809 |
View |
CK-20 |
Keratin 20 |
Keratin, type I cytoskeletal 20 |
diagnosis(metastasis) |
10985893 |
View |
CK-20 |
Keratin 20 |
Keratin, type I cytoskeletal 20 |
diagnosis(metastasis) |
10985893 |
View |
CK-20 |
Keratin 20 |
Keratin, type I cytoskeletal 20 |
diagnosis(metastasis) |
10985893 |
View |
CA72-4 |
N/A |
N/A |
diagnosis |
33099933 |
View |
CK-20 |
Keratin 20 |
Keratin, type I cytoskeletal 20 |
diagnosis(metastasis) |
10985893 |
View |
CK-20 |
Keratin 20 |
Keratin, type I cytoskeletal 20 |
diagnosis(metastasis) |
10985893 |
View |
telomerase |
N/A |
N/A |
prognosis(unfavorable) |
10920935 |
View |
metallothioneins |
N/A |
N/A |
diagnosis(aggressive behaviour) |
10878548 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
diagnosis(earliest endometrial precancers) |
10841828 |
View |
PTEN |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
diagnosis(earliest endometrial precancers) |
10841828 |
View |
Flt-4 |
fms related receptor tyrosine kinase 4 |
Vascular endothelial growth factor receptor 3 |
prognosis(unfavorable) |
10831352 |
View |
p16INK4aa |
Cyclin dependent kinase inhibitor 2A |
Tumor suppressor ARF |
prognosis(unfavorable) |
10656444 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
10600396 |
View |
MIB-1 |
MIB E3 ubiquitin protein ligase 1 |
E3 ubiquitin-protein ligase MIB1 |
prognosis(unfavorable) |
10600302 |
View |
CA15.3 |
N/A |
N/A |
diagnosis |
33099933 |
View |
anti-repp 86 |
N/A |
N/A |
prognosis(unfavorable) |
10452508 |
View |
KGFR |
Fibroblast growth factor receptor 2 |
Fibroblast growth factor receptor 2 |
prognosis(unfavorable) |
10427121 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
10376438 |
View |
HER-2/neu |
erb-b2 receptor tyrosine kinase 2 |
N/A |
prognosis(unfavorable) |
10202671 |
View |
PR |
Progesterone receptor |
Progesterone receptor |
prognosis(unfavorable) |
10053107 |
View |
cathepsin D (Cat D) |
Cathepsin D |
Cathepsin D |
prognosis(unfavorable) |
10027332 |
View |
Ki-S4 PA |
N/A |
N/A |
prognosis(unfavorable) |
9934583 |
View |
syndecan-1 |
Syndecan 1 |
Syndecan-1 |
prognosis(unfavorable) |
9857223 |
View |
Ki-67 |
marker of proliferation Ki-67 |
Proliferation marker protein Ki-67 |
prognosis(unfavorable) |
9829742 |
View |
PP14 |
progestagen associated endometrial protein |
Glycodelin |
diagnosis |
9804252 |
View |
p16 |
Cyclin dependent kinase inhibitor 2A |
Tumor suppressor ARF |
prognosis |
34473724 |
View |
MCM5 |
minichromosome maintenance complex component 5 |
DNA replication licensing factor MCM5 |
diagnosis(non-invasive aid) |
33059604 |
View |
PP14 |
progestagen associated endometrial protein |
Glycodelin |
diagnosis |
9804252 |
View |
CK-20 |
Keratin 20 |
Keratin, type I cytoskeletal 20 |
diagnosis |
9790796 |
View |
CK-20 |
Keratin 20 |
Keratin, type I cytoskeletal 20 |
diagnosis |
9790796 |
View |
PR |
Progesterone receptor |
Progesterone receptor |
prognosis(unfavorable) |
9648591 |
View |
ER |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
prognosis(unfavorable) |
9648591 |
View |
CA125 |
Mucin 16, cell surface associated |
N/A |
diagnosis |
9648586 |
View |
HER-2/neu |
erb-b2 receptor tyrosine kinase 2 |
N/A |
prognosis(unfavorable) |
9646853 |
View |
GST-pi |
Glutathione S-transferase pi 1 |
Glutathione S-transferase P |
prognosis(unfavorable) |
9570981 |
View |
c-Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
Transcription factor Jun |
prognosis(unfavorable) |
9570981 |
View |
melatonin |
N/A |
N/A |
diagnosis |
9473168 |
View |
MHC class I status |
major histocompatibility complex, class I-related |
Major histocompatibility complex class I-related gene protein |
treatment(resistance mechanism to immune checkpoint inhibition) |
33011747 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
9422988 |
View |
p21 |
Cyclin dependent kinase inhibitor 1A |
Cyclin-dependent kinase inhibitor 1 |
prognosis |
9422988 |
View |
cyclin A |
cyclin A2 |
Cyclin-A2 |
diagnosis |
9421074 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
diagnosis |
9421074 |
View |
Calretinin |
Calbindin 2 |
Calretinin |
diagnosis |
9390137 |
View |
CA15.3 |
N/A |
N/A |
prognosis(unfavorable) |
9218009 |
View |
c-erbB-2 |
Erb-b2 receptor tyrosine kinase 2 |
Receptor tyrosine-protein kinase erbB-2 |
diagnosis |
9167896 |
View |
CA 72-4 |
N/A |
|
prognosis |
9038731 |
View |
CA 72-4 |
N/A |
|
prognosis |
9038731 |
View |
PCNA |
Proliferating cell nuclear antigen |
Proliferating cell nuclear antigen |
prognosis(unfavorable) |
8936111 |
View |
MHC class I status |
major histocompatibility complex, class I-related |
Major histocompatibility complex class I-related gene protein |
treatment(selecting endometrial cancer patients for checkpoint inhibition) |
33011747 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
8936111 |
View |
c-erbB-2 protein |
Erb-b2 receptor tyrosine kinase 2 |
Receptor tyrosine-protein kinase erbB-2 |
prognosis(unfavorable) |
8936111 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
8761370 |
View |
desmoplakin I |
desmoplakin |
Desmoplakin |
diagnosis |
8697392 |
View |
desmoplakin II |
desmoplakin |
Desmoplakin |
diagnosis |
8697392 |
View |
desmoglein |
N/A |
N/A |
diagnosis |
8697392 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
8695259 |
View |
cathepsin D |
Cathepsin D |
Cathepsin D |
diagnosis |
8664123 |
View |
MIB-1 |
MIB E3 ubiquitin protein ligase 1 |
E3 ubiquitin-protein ligase MIB1 |
prognosis(unfavorable) |
8641618 |
View |
HER-2/neu |
erb-b2 receptor tyrosine kinase 2 |
N/A |
prognosis(unfavorable) |
8610771 |
View |
ER |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
prognosis(recurrence) |
32920817 |
View |
HER-2/neu |
erb-b2 receptor tyrosine kinase 2 |
N/A |
prognosis(unfavorable) |
8556702 |
View |
sIL-2R |
Interleukin 2 receptor subunit alpha |
Interleukin-2 receptor subunit alpha |
diagnosis |
8317901 |
View |
OVX1 |
N/A |
N/A |
diagnosis |
8137210 |
View |
OVX1 |
N/A |
N/A |
prognosis |
8137210 |
View |
CA19-9 |
N/A |
|
prognosis |
8088608 |
View |
CA 125 |
Mucin 16, cell surface associated |
N/A |
prognosis |
8088608 |
View |
CA 15-3 |
N/A |
|
prognosis(unfavorable) |
8088605 |
View |
CA 125 |
Mucin 16, cell surface associated |
N/A |
prognosis(unfavorable) |
8088605 |
View |
CA 125 |
Mucin 16, cell surface associated |
N/A |
diagnosis |
8008305 |
View |
EGFR |
epidermal growth factor receptor |
Epidermal growth factor receptor |
prognosis(unfavorable) |
7909788 |
View |
PR |
Progesterone receptor |
Progesterone receptor |
prognosis(recurrence) |
32920817 |
View |
cathepsin D |
Cathepsin D |
Cathepsin D |
prognosis |
7740849 |
View |
CA125 II |
N/A |
N/A |
diagnosis |
7737582 |
View |
colony-stimulating factor 1 |
Colony stimulating factor 1 |
Granulocyte-macrophage colony-stimulating factor |
prognosis(presence and activity (progression, stabilization, or regression) of primary or recurrent disease) |
7631667 |
View |
PP-4 |
N/A |
N/A |
diagnosis |
1833844 |
View |
Plasminogen activator inhibitor-type 2 (PAI-2) |
plasminogen activator |
N/A |
prognosis(unfavorable) |
1427403 |
View |
HER-2/neu |
erb-b2 receptor tyrosine kinase 2 |
N/A |
prognosis(unfavorable) |
1361478 |
View |
HER-2/neu |
erb-b2 receptor tyrosine kinase 2 |
N/A |
prognosis(unfavorable) |
1361478 |
View |
Citrullinated Histone H3 |
N/A |
N/A |
diagnosis(occurrence of NETosisA(neutrophil extracellular traps)) |
35449078 |
View |
VEGFR2 |
kinase insert domain receptor |
Vascular endothelial growth factor receptor 2 |
diagnosis |
35241527 |
View |
PD-1 |
programmed cell death 1 |
Programmed cell death protein 1 |
prognosis(favorable) |
36581331 |
View |
P53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(recurrence) |
32920817 |
View |
CD39 |
ectonucleoside triphosphate diphosphohydrolase 1 |
Ectonucleoside triphosphate diphosphohydrolase 1 |
prognosis(favorable) |
36581331 |
View |
PD-1 |
programmed cell death 1 |
Programmed cell death protein 1 |
prognosis(favorable) |
36581331 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
36251972 |
View |
Pirh2 |
N/A |
N/A |
prognosis(unfavorable) |
36251972 |
View |
L1CAM |
L1 cell adhesion molecule |
Neural cell adhesion molecule L1 |
prognosis(unfavorable) |
36251972 |
View |
SLeX |
N/A |
N/A |
prognosis(unfavorable) |
35729354 |
View |
SLeA |
N/A |
N/A |
prognosis(unfavorable) |
35729354 |
View |
LeY |
N/A |
N/A |
prognosis(unfavorable) |
35729354 |
View |
Musashi-1 |
MSI1 |
RNA-binding protein Musashi homolog 1 |
treatment(sensitizes cells to radiation) |
35619161 |
View |
CA125 |
Mucin 16, cell surface associated |
N/A |
diagnosis(lymphovascular space invasion and lymph node metastasis ) |
36396713 |
View |
Ki67 |
marker of proliferation Ki-67 |
Proliferation marker protein Ki-67 |
prognosis(recurrence) |
32920817 |
View |
YTHDF2 |
YTHDF2 |
YTH domain-containing family protein 2 |
diagnosis(endometrial endometrioid adenocarcinoma ) |
35512522 |
View |
Claudin‑9 |
|
Claudin-9 |
prognosis(unfavorable) |
36129146 |
View |
CD47 |
N/A |
Leukocyte surface antigen CD47 |
prognosis(favorable) |
34282107 |
View |
PD-L1 |
CD274 |
Programmed cell death 1 ligand 1 |
treatment(therapeutic target) |
35220229 |
View |
PD-L1 |
CD274 |
Programmed cell death 1 ligand 1 |
treatment(therapeutic target) |
35804040 |
View |
TIM-3 |
HAVCR2 |
Hepatitis A virus cellular receptor 2 |
treatment(therapeutic target) |
35804040 |
View |
B7-H3 |
CD276 |
CD276 antigen |
treatment(therapeutic target) |
35804040 |
View |
Suprabasin (SBSN) isoform 2 |
SBSN |
Suprabasin |
prognosis(unfavorable) |
35216190 |
View |
Suprabasin (SBSN) isoform 2 |
SBSN |
Suprabasin |
prognosis(unfavorable) |
35216190 |
View |
PRAME |
Melanoma antigen preferentially |
PRAME |
diagnosis |
35512215 |
View |
CDK9 |
cyclin dependent kinase 9 |
N/A |
prognosis(unfavorable) |
32901849 |
View |
PRAME |
Melanoma antigen preferentially |
PRAME |
treatment(therapeutic target) |
35512215 |
View |
NHP2 |
NHP2 |
H/ACA ribonucleoprotein complex subunit 2 |
prognosis(favorable) |
35054812 |
View |
chondoadherin-like |
diagnosis |
36052469 |
diagnosis |
36052469 |
View |
Claudin‑9 |
Claudin-9 |
Claudin-9 |
prognosis |
36129146 |
View |
PKN1 |
PKN1 |
Serine/threonine-protein kinase N1 |
prognosis |
35533253 |
View |
apolipoprotein E |
APOE |
Apolipoprotein E |
prognosis |
36123916 |
View |
CA125 |
MUC16 (CA125, FLJ14303) |
Mucin-16 |
diagnosis(predictor of endometrial cancer lymphovascular space invasion and lymph node ) |
36396713 |
View |
HE4 |
WFDC2 (dJ461P17.6, EDDM4, HE4, WAP5) |
WAP four-disulfide core domain protein 2 |
treatment |
36715558 |
View |
C-reactive protein |
CRP (PTX1) |
C-reactive protein |
prognosis(unfavorable) |
34802721 |
View |
L1CAM |
L1CAM (CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1) |
Neural cell adhesion molecule L1 |
prognosis(unfavorable) |
36251972 |
View |
CDK9 |
cyclin dependent kinase 9 |
N/A |
treatment(therapeutic target) |
32901849 |
View |
p53 |
TP53 (LFS1, p53) |
Cellular tumor antigen p53 |
prognosis(unfavorable) |
36251972 |
View |
Pirh2 |
RCHY1 |
RING finger and CHY zinc finger domain-containing protein 1 |
prognosis(unfavorable) |
36251972 |
View |
YKL-40 |
CHI3L1 (GP39, YK-40, YKL40) |
Chitinase-3-like protein 1 |
diagnosis |
34974784 |
View |
PDL-1 |
Programmed cell death 1 ligand 1 |
CD274 |
treatment(therapeutic target) |
35220229 |
View |
SOX17 |
SOX17 |
Transcription factor SOX-17 |
diagnosis |
36788073 |
View |
Ki-67 |
MKI67 (MIB-1, PPP1R105) |
Proliferation marker protein Ki-67 |
diagnosis |
35891746 |
View |
PD-L1 |
CD274 (B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1) |
Programmed cell death 1 ligand 1 |
treatment(therapeutic target) |
35804040 |
View |
TIM-3 |
HAVCR2 (CD366, FLJ14428, Tim-3, TIM3, TIMD3) |
Hepatitis A virus cellular receptor 2 |
treatment(therapeutic target) |
35804040 |
View |
B7-H3 |
CD276 (B7-H3, B7H3, B7RP-2) |
CD276 antigen |
treatment(therapeutic target) |
35804040 |
View |
Cyclin D1 |
CCND1 (BCL1, D11S287E, PRAD1, U21B31) |
CCND1 (BCL1, D11S287E, PRAD1, U21B31) |
prognosis(unfavorable) |
35156640 |
View |
nuclear beta-catenin |
Catenin beta 1 |
Catenin beta-1 |
NOT PROGONSIS |
32897964 |
View |
p53 |
Cellular tumor antigen p53 |
TP53 (LFS1, p53) |
prognosis(unfavorable) |
35156640 |
View |
Ki-67 |
MKI67 (MIB-1, PPP1R105) |
Proliferation marker protein Ki-67 |
prognosis(unfavorable) |
35156640 |
View |
V-domain Ig-containing suppressor of T-cell activation |
|
|
prognosis(favorable) |
34493823 |
View |
ARID1B |
ARID1B |
AT-rich interactive domain-containing protein 1B |
diagnosis(differentiation between DDEC/UDEC and NEC) |
35394077 |
View |
SMARCA4 |
SMARCA4 |
Transcription activator BRG1 |
diagnosis(differentiation between DDEC/UDEC and NEC) |
35394077 |
View |
SMARCB1 |
SMARCB1 |
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 |
diagnosis(differentiation between DDEC/UDEC and NEC) |
35394077 |
View |
Zinc finger E-box binding homeobox 1 |
ZEB2 |
Zinc finger E-box-binding homeobox 2 |
diagnosis |
35478361 |
View |
sine oculis homeobox homolog 1 |
SIX1 |
Homeobox protein SIX1 |
prognosis |
35379118 |
View |
indolamine 2,3-dioxygenase 1 |
IDO1 (IDO, INDO) |
indolamine 2,3-dioxygenase 1 |
prognosis(unfavorable) |
36119020 |
View |
TARS |
TARS1, TARS |
Threonine--tRNA ligase 1 |
prognosis(unfavorable) |
36881401 |
View |
PR |
Progesterone receptor |
Progesterone receptor |
diagnosis |
34418427 |
View |
VDAC1 |
Voltage-dependent anion-selective channel protein 1 |
Voltage-dependent anion-selective channel protein 1 |
prognosis(unfavorable) |
32829673 |
View |
lymphocyte activation gene-3 |
LAG3 |
Lymphocyte activation gene 3 protein |
prognosis(favorable) |
35749914 |
View |
lymphocyte activation gene-3 |
LAG3 |
Lymphocyte activation gene 3 protein |
treatment(therapeutic target) |
35749914 |
View |
CD10 |
MME (CALLA, CD10, NEP) |
Neprilysin |
diagnosis |
34689374 |
View |
SOX2 |
SOX2 |
Transcription factor SOX-2 |
diagnosis |
35331811 |
View |
HER2 |
ERBB2 (CD340, HER-2, HER2, NEU, NGL) |
|
diagnosis |
33782344 |
View |
Ki67 |
MKI67 (MIB-1, PPP1R105) |
Proliferation marker protein Ki-67 |
diagnosis(deep myometrial invasion) |
36918859 |
View |
CA125 |
MUC16 (CA125, FLJ14303) |
Mucin-16 |
diagnosis(deep myometrial invasion) |
36918859 |
View |
HER2 |
ERBB2 (CD340, HER-2, HER2, NEU, NGL) |
|
diagnosis |
37094656 |
View |
L1CAM |
L1CAM (CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1) |
Neural cell adhesion molecule L1 |
treatment(platinum response) |
35429348 |
View |
DJ-1 |
Parkinson disease protein 7 |
PARK7 (DJ-1, DJ1, GATD2) |
prognosis |
35575391 |
View |
VDAC1 |
Voltage-dependent anion-selective channel protein 1 |
Voltage-dependent anion-selective channel protein 1 |
prognosis(unfavorable) |
32829673 |
View |
HE4 |
WFDC2 (dJ461P17.6, EDDM4, HE4, WAP5) |
WFDC2 (dJ461P17.6, EDDM4, HE4, WAP5) |
prognosis |
35575391 |
View |
KRT15 |
Keratin, type I cytoskeletal 15 |
KRT15 |
prognosis |
35866777 |
View |
MMRd/MSI-H |
|
|
treatment |
34902958 |
View |
Ki67 |
MKI67 (MIB-1, PPP1R105) |
Proliferation marker protein Ki-67 |
prognosis(unfavorable) |
36697084 |
View |
E-cadherin |
CDH1 (CD324, UVO, uvomorulin) |
Cadherin-1 |
prognosis(unfavorable) |
36697084 |
View |
р53+FOXP3-c-Myc+ |
|
|
diagnosis(endometrioid carcinoma of the endometrium) |
36325701 |
View |
HER2 |
ERBB2 (CD340, HER-2, HER2, NEU, NGL) |
|
treatment(therapeutic target) |
36516643 |
View |
SPRR1B |
SPRR1B |
Cornifin-B |
diagnosis |
36807337 |
View |
CRNN |
CRNN, C1orf10, DRC1, PDRC1, SEP53 |
Cornulin |
diagnosis |
36807337 |
View |
CALML3 |
CALML3 |
Calmodulin-like protein 3 |
diagnosis |
36807337 |
View |
VDAC2 |
Voltage dependent anion channel 2 |
Voltage-dependent anion-selective channel protein 2 |
prognosis(unfavorable) |
32829673 |
View |
CALML3 |
CALML3 |
Calmodulin-like protein 3 |
diagnosis |
36807337 |
View |
TXN |
TXN |
Thioredoxin |
diagnosis |
36807337 |
View |
FABP5 |
FABP5 |
Fatty acid-binding protein 5 |
diagnosis |
36807337 |
View |
C1RL |
C1RL |
Complement C1r subcomponent-like protein |
diagnosis |
36807337 |
View |
MMP9 |
MMP9 (CLG4B) |
Matrix metalloproteinase-9 |
diagnosis |
36807337 |
View |
ECM1 |
ECM1 |
Extracellular matrix protein 1 |
diagnosis |
36807337 |
View |
S100A7 |
S100A7 |
Protein S100-A7 |
diagnosis |
36807337 |
View |
vimentin |
VIM |
Vimentin |
prognosis(unfavorable) |
35320951 |
View |
CA125 |
MUC16 (CA125, FLJ14303) |
Mucin-16 |
diagnosis(predict lymph node metastasis) |
36596280 |
View |
HE4 |
WFDC2 (dJ461P17.6, EDDM4, HE4, WAP5) |
WFDC2 (dJ461P17.6, EDDM4, HE4, WAP5) |
diagnosis(predict lymph node metastasis) |
36596280 |
View |
VDAC2 |
Voltage dependent anion channel 2 |
Voltage-dependent anion-selective channel protein 2 |
prognosis(unfavorable) |
32829673 |
View |
ER |
ESRRA (ERR1, ERRa, ERRalpha, ESRL1, NR3B1) |
|
prognosis |
36690721 |
View |
HER2 |
ERBB2 (CD340, HER-2, HER2, NEU, NGL) |
|
treatment(therapeutic target) |
36939053 |
View |
HER2 |
ERBB2 (CD340, HER-2, HER2, NEU, NGL) |
|
prognosis(unfavorable) |
35611517 |
View |
β-catenin |
|
|
diagnosis |
36939046 |
View |
Pax2 |
PAX2 |
Paired box protein Pax-2 |
diagnosis |
36939046 |
View |
Pten |
Phosphatase and tensin homolog |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
diagnosis |
36939046 |
View |
ERα |
Estrogen related receptor alpha |
Steroid hormone receptor ERR1 |
diagnosis(prediction of risk of lymph node metastasis in early-stage endometrial cancer ) |
34456278 |
View |
PR |
Progesterone receptor |
Progesterone receptor |
diagnosis(prediction of risk of lymph node metastasis in early-stage endometrial cancer ) |
34456278 |
View |
Ki67 |
MKI67 (MIB-1, PPP1R105) |
Proliferation marker protein Ki-67 |
diagnosis(prediction of risk of lymph node metastasis in early-stage endometrial cancer ) |
34456278 |
View |
P53 |
Cellular tumor antigen p53 |
TP53 (LFS1, p53) |
diagnosis(prediction of risk of lymph node metastasis in early-stage endometrial cancer ) |
34456278 |
View |
TROP2 |
Tumor associated calcium signal transducer 2 |
Tumor-associated calcium signal transducer 2 |
prognosis(unfavorable) |
32769331 |
View |
Lymphocyte activation gene (LAG)-3 |
LAG3 |
Lymphocyte activation gene 3 protein |
treatment(therapeutic target) |
36509464 |
View |
TROP2 |
Tumor associated calcium signal transducer 2 |
Tumor-associated calcium signal transducer 2 |
prognosis(unfavorable) |
32769331 |
View |
HE4 |
WAP four-disulfide core domain 2 |
WAP four-disulfide core domain protein 2 |
diagnosis |
32711295 |
View |
p53 |
tumor protein p53 |
Cellular tumor antigen p53 |
diagnosis(predicting TP53 mutations) |
32703491 |
View |
MSX1 |
msh homeobox 1 |
Homeobox protein MSX-1 |
prognosis(favorable) |
32630554 |
View |
MSX1 |
msh homeobox 1 |
Homeobox protein MSX-1 |
prognosis(favorable) |
32630554 |
View |